> The phoenicians invented money---but why so little?
>
> (Johann Nestroy)
>
> Mother Nature invented glutathione---but why so much?

Introduction and Scope {#s001}
======================

G[lutathione]{.smallcaps} [is a major thiol currency]{.smallcaps} and pivotal adapter molecule in metabolism. In contrast to traditional theories on nonenzymatic redox buffering, glutathione exerts multiple functions far beyond the maintenance of a reducing intracellular milieu ([@B60]). The versatility of glutathione metabolism is reflected by at least five nonrelated protein folds that have been optimized for glutathione interaction and catalysis in the course of evolution. These glutathione-dependent proteins allow eukaryotes and many prokaryotes to metabolize a plethora of electrophilic substances, for example, to cope with chemical challenges that result from a glycolysis-driven aerobic lifestyle and the exposure to xenobiotics ([@B60]). The flexible chemistry of glutathione depends on its cysteinyl thiol group, whereas the γ-glutamyl peptide bond, as well as one positive and two negative charges, facilitates its recognition by enzymes. The repertoire of proteins and electrophiles that is considered to play a role in glutathione metabolism is summarized in [Table 1](#T1){ref-type="table"} and [Figure 1](#f1){ref-type="fig"} and will serve as a starting point for this review. Among the multiple astonishing features of reduced glutathione (GSH) is its millimolar concentration in many organisms ([@B60], [@B153], [@B189], [@B196], [@B212], [@B217]). Which processes necessitate such a high concentration? On the contrary, how are some reactions between electrophiles and GSH prevented or, in other words, slowed down and kinetically uncoupled under these conditions? Furthermore, which of the enzymatic or nonenzymatic processes in glutathione metabolism are really relevant *in vivo*? These questions are difficult to address taking into account that (i) most of the genes encoding the proteins in [Table 1](#T1){ref-type="table"} can be successfully knocked out in yeast and many other organisms and that (ii) noticeable phenotypes often require combined gene deletions or extreme chemical challenges ([@B29], [@B60], [@B73], [@B105], [@B106], [@B119], [@B132], [@B163], [@B168], [@B184], [@B195], [@B240]). A plausible explanation for the robustness of glutathione metabolism is that cells use redundant metabolic (backup) systems, for example, duplicated genes ([@B297]) or cytosolic and mitochondrial thioredoxin (Trx)/Trx reductase (TrxR) systems that can complement the loss of glutathione reductase in the same compartment ([@B11], [@B105], [@B109], [@B272]). Gene deletions can also trigger compensatory mechanisms that alter the proteome, which might affect, for example, the transport of metabolites or xenobiotics. Alternative explanations for mild or absent knockout phenotypes could be that some branches of glutathione metabolism in [Figure 1](#f1){ref-type="fig"} are either *apparently* irrelevant for survival because of the chosen experimental conditions, or are *de facto* irrelevant because of incorrect assumptions and concepts. How can we discriminate between these scenarios?

![**Electrophilic metabolites and substrates that are considered to play a role in glutathione metabolism.** Interaction sites between the electrophile and the thiolate group of glutathione (or the glutathione-dependent enzyme) are indicated by *arrowheads*. Enzymes are listed in [Table 1](#T1){ref-type="table"}. See Ref. ([@B60]) for details on the enzymatic mechanisms.](fig-1){#f1}

###### 

[Overview of Glutathione-Dependent Enzymes]{.smallcaps}

  *Protein*                               *Fold and family*                                                        *Glutathione-dependent function*^[a](#tf1){ref-type="table-fn"}^                                                                               *Refs.*
  --------------------------------------- ------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------
  GR                                      Pyridine nucleotide disulfide oxidoreductase family                      NADPH + H^+^ + GSSG →2 GSH + NADP^+^                                                                                                           ([@B60])
                                                                                                                   • Link the NADPH pool with the thiol/disulfide pool                                                                                             
                                                                                                                   • Reduce GSSG and maintain high GSH concentrations                                                                                              
  Grx^[b](#tf2){ref-type="table-fn"}^     Thioredoxin superfamily                                                  • Catalyze thiol/disulfide exchange reactions (*e.g*., deglutathionylations or the reduction of ribonucleotide reductase)                      ([@B56], [@B60], [@B65], [@B97], [@B163], [@B214])
                                                                                                                   • Contribute to iron--sulfur cluster biosynthesis                                                                                               
                                                                                                                   • Play a regulatory role in iron and redox metabolism                                                                                           
  PDI^[b](#tf2){ref-type="table-fn"}^     Thioredoxin superfamily                                                  • Catalyze thiol/disulfide exchange reactions during oxidative protein folding in the endoplasmic reticulum^[c](#tf3){ref-type="table-fn"}^    ([@B8], [@B36], [@B209], [@B286])
                                                                                                                   • Reduce misfolded substrates of the ERAD pathway^[c](#tf3){ref-type="table-fn"}^                                                               
                                                                                                                   • Act as redox regulator of other proteins^[c](#tf3){ref-type="table-fn"}^                                                                      
  GPx^[b](#tf2){ref-type="table-fn"}^     Thioredoxin superfamily                                                  ROOH + 2 R′SH→R′SS′R + ROH + H~2~O                                                                                                             ([@B34], [@B35], [@B60], [@B273])
                                                                                                                   • Reduce and detoxify hydroperoxides using Trx and/or GSH                                                                                       
                                                                                                                   • Act as redox sensor in signal transduction cascades                                                                                           
  Prx^[b](#tf2){ref-type="table-fn"}^     Thioredoxin superfamily                                                  ROOH + 2 R′SH→R′SS′R + ROH + H~2~O                                                                                                             ([@B34], [@B60], [@B113], [@B238])
                                                                                                                   • Reduce hydroperoxides using Trx, Grx, and/or GSH                                                                                              
                                                                                                                   • Act as redox sensor in signal transduction cascades                                                                                           
  GST^[b](#tf2){ref-type="table-fn"}^     Thioredoxin superfamily (or DsbA-like^[d](#tf4){ref-type="table-fn"}^)   • Conjugate and detoxify drugs, xenobiotics, *etc.*                                                                                            ([@B30], [@B60], [@B117])
                                                                                                                   • Reduce hydroperoxides and/or disulfides                                                                                                       
                                                                                                                   • Catalyze isomerizations (*e.g*., during Phe/Tyr-degradation or steroid and eicosanoid metabolism)                                             
                                                                                                                   • Exert regulatory functions by protein--protein interaction                                                                                    
  MAPEG^[b](#tf2){ref-type="table-fn"}^   MAPEG domain-like fold                                                   [*M*]{.ul}embrane-[*a*]{.ul}ssociated [*p*]{.ul}roteins with divergent functions in [*e*]{.ul}icosanoid and [*g*]{.ul}lutathione metabolism:   ([@B60], [@B135], [@B176])
                                                                                                                   • Catalyze conjugations and (hydro)peroxide reductions                                                                                          
                                                                                                                   • Catalyze eicosanoid isomerization and conversions                                                                                             
  Glo1                                    Vicinal oxygen chelate superfamily                                       • Convert and detoxify 2-oxoaldehydes (isomerase step)                                                                                         ([@B60], [@B61], [@B129], [@B256], [@B270])
                                                                                                                   • Can have regulatory or unknown functions                                                                                                      
  Glo2^[b](#tf2){ref-type="table-fn"}^    β-lactamase fold binuclear metallo-hydrolase family                      • Convert and detoxify 2-oxoaldehydes (thioesterase step)                                                                                      ([@B60], [@B61], [@B129], [@B256], [@B270])
                                                                                                                   • Hydrolyze alternative non-glutathione thioesters                                                                                              
                                                                                                                   • Can have regulatory or unknown functions                                                                                                      
  GSNOR^[e](#tf5){ref-type="table-fn"}^   Alcohol dehydrogenase fold                                               • Catalyze the NAD^+^-dependent oxidation of formaldehyde                                                                                      ([@B24], [@B173], [@B260])
                                                                                                                   • Catalyze the NADH-dependent reduction of GSNO^[f](#tf6){ref-type="table-fn"}^                                                                 
                                                                                                                   • Might have regulatory functions                                                                                                               

Physiological functions can differ significantly among isoforms and organisms.

Organisms often harbor several isoforms of these proteins.

The relevance of GSH and GSSG for these processes is not fully understood.

The α-helical domain of kappa class GST is inserted and not fused to the Trx domain.

Identical to class III alcohol dehydrogenase (ADH5) or GSH-dependent formaldehyde dehydrogenase.

A similar activity was reported for NADPH-dependent human carbonyl reductase 1.

Glo1, glyoxalase 1; Grx, glutaredoxins; GPx, glutathione peroxidase; GR, glutathione reductase; GSNOR, GSNO reductase; GST, glutathione transferase; PDI, protein disulfide isomerase; Prx, peroxiredoxin; ROOH, hydroperoxide; Trx, thioredoxin.

The redox metabolism of organelles and cells predominantly depends on kinetic instead of thermodynamic constraints as emphasized previously ([@B34], [@B60], [@B65], [@B87], [@B91]). In contrast to the frequently used concept of nonenzymatic redox buffering, which is based on the Gibbs free energy of redox reactions at equilibrium, cellular systems use enzymes and work under steady-state conditions. Thus, reactions with favorable thermodynamics might be physiologically irrelevant because of a lack of catalyst, whereas less favorable reactions might occur because of a constant metabolic flux and energetic coupling. It is therefore problematic to rely on equilibrium-based redox potentials and to use the term "redox buffer" to rank redox reactions *in vivo*. A better quantitative approach to judge the physiological relevance of a glutathione-dependent reaction is to determine its rate and to compare it with potentially competing reactions. The ratio between the reaction rates of one and the same compound with different partners then tells us whether a kinetic competition is likely to occur. A very slow or absent reaction also tells us whether a process is kinetically uncoupled from glutathione metabolism, which is a prerequisite for the accumulation or stability of an electrophile at high GSH concentrations (*e.g*., of an iron--sulfur cluster or a protein disulfide bond). Reaction rates are described by rate equations ([@B13], [@B28], [@B250]). For example, if electrophile "S" either reacts in an irreversible bimolecular elementary reaction with GSH (reaction 1) or as a substrate with an enzyme "E" that obeys Michaelis--Menten kinetics (reaction 2), rate equations [Eqs. 1](#eq3){ref-type="tex-math"} and [2](#eq4){ref-type="tex-math"} describe the concentration changes of "S" and products "P" and "Q" over time: $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
[ { \rm{S}} ] + [ { \rm{GSH}} ]  \xrightarrow{{k_2}} [ { \rm{P}} ] \tag{1}
\end{align*}
\end{document}$$ $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
[ { \rm { S } } ] + [ { \rm { \not E } } ] \xrightarrow{k_{\rm cat}} [ { { { \rm \not E } } } ] + [ { \rm { Q } } ] \tag { 2 }
\end{align*}
\end{document}$$ $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
{ v_1 } = { \frac { - d [ { \rm { S } } ] }  { d { \rm { t } } } }
= { \frac { d [ { \rm { P } } ] }  { d { \rm { t } } } } = { k_2 }
[ { \rm { S } } ] [ { \rm { GSH } } ] \tag {{\rm eq. 1}}
\end{align*}
\end{document}$$ $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
{ v_2 } = { \frac { - d [ { \rm { S } } ] }  { d { \rm { t } } } }
= { \frac { d [ { \rm { Q } } ] }  { d { \rm { t } } } } = { \frac
{ { k_ { { \rm { cat } } } } [ { \rm { E } } ] [ { \rm { S } } ] }
{ { K_ { \rm { m } } } + [ { \rm { S } } ] } } \tag {{\rm eq. 2}}
\end{align*}
\end{document}$$

The more competing compounds and enzymes are involved, the more reaction rates have to be considered. Rate equations have to be determined empirically. They depend on the type of mechanism and the rate-limiting elementary reaction ([@B13]). [Eqs. 1](#eq3){ref-type="tex-math"} and [2](#eq4){ref-type="tex-math"} are suited for the description of many biochemical reactions. Hence, potential kinetic competitions in biochemical systems depend on rate constants and the concentrations of the reaction partners (*e.g*., on the second-order rate constant *k*~2~ and the concentration of GSH). To address potential kinetic competitions in glutathione metabolism, we need to gather information on the following factors, which I will discuss in the subsequent sections. (i) The compartment-specific metabolite and substrate repertoire, (ii) the metabolite and substrate concentrations, (iii) kinetic parameters such as rate constants and *K*~m~ values, (iv) the compartment-specific enzyme repertoire, (v) the enzyme concentrations, and (vi) the enzyme mechanisms. The effects of some of these factors---for example, the presence or absence of a specific enzyme---are obvious, whereas other factors, such as the enzyme mechanism, have more subtle consequences and are easy to miss. The aim of this review is to point out the relevance of the aforementioned factors on potential kinetic competitions and to highlight the missing puzzle pieces for a complete understanding of glutathione metabolism. Furthermore, I will apply these factors to discuss how processes such as redox sensing, protein disulfide formation, and iron--sulfur cluster binding could be kinetically uncoupled from glutathione-dependent catalysis at physiological GSH concentrations.

Compartment-Specific Metabolite and Substrate Repertoires {#s002}
=========================================================

The electrophiles that are considered to play a role in glutathione metabolism are extremely diverse and include sulfur-, oxygen-, nitrogen-, carbon-, or iron-containing metabolites or substrates ([Fig. 1](#f1){ref-type="fig"}) ([@B60]). These compounds can be subdivided into the following categories: (i) unknown, (ii) candidate, and (iii) established electrophiles of glutathione metabolism. Before we start with these categories, we will first consider what is known about the compartmentalization of glutathione itself.

Subcellular distribution and transport of glutathione {#s003}
-----------------------------------------------------

At the current stage, we cannot reject the null hypothesis that there are subcellular compartments that do not utilize glutathione, or, in other words, we cannot fully exclude that some subcellular compartments lack GSH, glutathione disulfide (GSSG), or glutathione conjugates. GSH biosynthesis takes place in the cytosol ([@B167]) and in chloroplasts ([@B284]). Glutathione reductase (GR) uses NADPH to convert GSSG to two molecules of GSH in the cytosol, the mitochondrial matrix, and in chloroplasts ([Table 1](#T1){ref-type="table"}) ([@B60]). Thus, it is assumed and partially shown that GSH, GSSG, and/or glutathione conjugates are transferred from these to other compartments by permeable pores, specific transporters, or vesicles ([Fig. 2](#f2){ref-type="fig"}).

![**Subcellular distribution and transport of glutathione.** Pores, transporters, and established as well as hypothetical glutathione contents are highlighted. Enzymes and metabolic pathways are omitted for clarity. Unknown transporters are shaded in *gray* and suggested transport processes are highlighted by *dotted arrows*. Please note that the transporters might differ among eukaryotes and that the pathways are partially based on *in vitro* data. For example, the carrier proteins for the import of GSH into the mitochondrial matrix have been characterized in mammals but not in yeast and the import of *S*-[d]{.smallcaps}-lactoylglutathione has been demonstrated for isolated rat mitochondria. GSX, sum of glutathione conjugates, GSOH, GSNO, hemithioacetals, and so on; IMS, mitochondrial intermembrane space; 2-OG, 2-oxoglutarate; P~i~, inorganic phosphate; SLG, *S*-[d]{.smallcaps}-lactoylglutathione. For transporters and details, see the [Subcellular Distribution and Transport of Glutathione](#s003){ref-type="sec"} section.](fig-2){#f2}

Pores between the cytosol and the corresponding organelle include the nuclear pore complex ([@B148]), porin in the outer mitochondrial membrane ([@B150]) and the transient translocation pore in peroxisomes ([@B182]). Can glutathione freely diffuse across these pores? The glutathione pool in the mitochondrial intermembrane space was shown to equilibrate very rapidly with the cytosol ([@B150]). This was also shown for the cytosol and nucleus in yeast ([@B58]), whereas nuclear GSH was suggested to accumulate in proliferating mammalian cells ([@B98]), contradicting a free diffusion across the nuclear pore. Whether glutathione enters peroxisomes across the translocation pore has not been shown so far but has been hypothesized based on the presence of the glutathione transferase (GST) kappa ([@B7]), which is found in mitochondria and peroxisomes in a variety of eukaryotes ([@B60]).

The inner mitochondrial membrane does not contain pores and has a tightly controlled permeability. The GSH content in the matrix of mammalian mitochondria was shown to partially depend on a dicarboxylate carrier (catalyzing an antiport with inorganic phosphate) and a 2-oxoglutarate carrier (catalyzing an antiport with 2-oxoglutarate) ([Fig. 2](#f2){ref-type="fig"}) ([@B15]). ABC transporters with a reported preference for GSSG or glutathione conjugates include (i) diverse multidrug resistance-associated proteins (MRP) in the plasma membrane of mammals ([@B15]), (ii) Atm1 and its homologues in the plasma membrane of bacteria and the inner mitochondrial membrane ([@B158], [@B245], [@B259]), and (iii) yeast cadmium factor 1 (Ycf1) in the vacuole ([@B162], [@B192]). All these transporters are ATPases and actively pump GSSG or glutathione conjugates across the membrane. Furthermore, yeast can import GSH (and also GSSG) with the help of the proton-coupled oligopeptide transporter Opt1 (Hgt1) ([@B32], [@B210]). Its homologue Opt2 is found in peroxisomes and might export GSSG ([@B76]) (yeast does not have a GST kappa isoform that could form glutathione conjugates). Vesicular transport of GSH is assumed to affect the organelles that pinch off from the secretory pathway and their glutathione content could therefore depend on the concentrations in the endoplasmic reticulum. However, experimental evidence for the *in vivo* transport of glutathione into subcellular compartments is in most cases surprisingly scarce or absent ([Fig. 2](#f2){ref-type="fig"}) ([@B15], [@B272]) (see also the [Glutathione Concentrations](#s012){ref-type="sec"} section).

Orphan proteins and unknown metabolites and substrates {#s004}
------------------------------------------------------

Considering the diversity of metabolites and proteins in glutathione metabolism, it is not surprising that the compartment-specific presence or identity of several of the electrophiles in [Figure 1](#f1){ref-type="fig"} is unknown. For example, the identification of true disulfide substrates of enzymatically active dithiol glutaredoxins (Grx) is still ongoing. We are only beginning to understand how important they are, for example, how relevant the recently identified Grx substrates sirtuin 1, CRMP2, or DJ-1 are for vascular and neuronal development or degeneration ([@B33], [@B99], [@B141]). Likewise, physiological substrates of several GST and MAPEG ([*m*]{.ul}embrane-[*a*]{.ul}ssociated [*p*]{.ul}roteins with divergent functions in [*e*]{.ul}icosanoid and [*g*]{.ul}lutathione metabolism) still remain to be identified, even though there are a variety of established functions of these enzymes in vertebrates, plants, and bacteria ([Table 1](#T1){ref-type="table"} and [Fig. 1](#f1){ref-type="fig"}) ([@B5], [@B30], [@B60], [@B117]). One probable reason for orphan GST- and MAPEG isoforms without established physiological substrates is that bacteria or eukaryotic model organisms are usually grown in the absence of xenobiotics, which are produced by competing microbes in real ecosystems. The absence of a growth defect for a knockout strain under optimized or even axenic laboratory conditions can therefore result in an underestimation of the true relevance of a potentially essential GST- or MAPEG-dependent detoxification process. As reviewed previously ([@B60], [@B61], [@B279]), very little is also known about the physiological substrates of insular glyoxalases 2 (Glo2), which are sometimes found in mitochondria, plastids, or the cytosol ([@B29], [@B55], [@B281], [@B290]) and have a hydrolase activity for glutathione- and other thioesters *in vitro* ([@B2], [@B280], [@B290]). The presence of such orphan proteins might point to novel metabolic pathways. A recent study on isolated mammalian mitochondria revealed, for example, that glutathione can be taken up as *S*-[d]{.smallcaps}-lactoylglutathione, which is subsequently hydrolyzed by Glo2 yielding GSH and [d]{.smallcaps}-lactate in the mitochondrial matrix ([Fig. 2](#f2){ref-type="fig"}) ([@B9]).

Other examples of orphan proteins without a defined partner are found in the monothiol Grx repertoire of *Saccharomyces cerevisiae*: yeast has three monothiol Grx isoforms (ScGrx3--5) that are pivotal for iron homeostasis in the mitochondrial matrix, the cytosol, and the nucleus ([@B214], [@B241]). Two additional membrane-anchored monothiol Grx isoforms, termed ScGrx6 and ScGrx7, were identified in the secretory pathway ([@B132], [@B184]). Both proteins are highly similar and catalyze GSH-dependent thiol/disulfide exchange reactions ([@B23], [@B169], [@B183]), but have no established substrates *in vivo*. In contrast to ScGrx7, ScGrx6 also binds iron--sulfur clusters *in vitro* ([@B183]) in analogy to ScGrx3-5 ([@B161], [@B228], [@B302]). Furthermore, radioactive iron ions were bound to the catalytic cysteine of ScGrx6 after immunoprecipitation from cell lysates ([@B132]). Taken together, these findings might point to a role of ScGrx6 in iron metabolism. However, except for calcium signaling ([@B230]) and the interdependent export of a complex between the iron-oxidoreductase Fet3 and the transporter Ftr1 ([@B244], [@B262]), nothing appears to be known about the relevance of the endoplasmic reticulum and the Golgi complex for metal ion homeostasis or about the existence of nonheme iron ions in the secretory pathway.

Candidate proteins and substrates {#s005}
---------------------------------

Moving on from unknown metabolites and substrates, candidate proteins await us at the next level of uncertainty. Candidates are often identified after chemical labeling, affinity chromatography, and/or mass spectrometry ([@B54], [@B111], [@B133], [@B160], [@B200], [@B243], [@B247], [@B264], [@B267], [@B289]). For example, numerous proteins have cysteine residues that form intramolecular disulfide bonds or that can undergo a glutathionylation, that is, form a mixed disulfide bond with glutathione *in vitro*. The disulfide bonds can be reduced again by Grx and such reversible thiol/disulfide exchange reactions are used to capture and identify candidate proteins ([@B4], [@B163], [@B187], [@B243], [@B247], [@B264], [@B283]). For many of these candidates, however, it remains to be clarified whether and how disulfide bond formation and glutathionylation occur under physiological conditions ([@B65]) (see also the [Kinetic Competitions for GSSG and GSSR](#s036){ref-type="sec"} section). False-positive hits can, for example, result from extreme nonphysiological treatments with oxidants or from (unavoidable) protein-dependent methodological pitfalls such as incomplete thiol blocking with alkylating agents before or after cell lysis ([@B102], [@B254], [@B296]).

The situation is somehow similar regarding the repertoire of potential protein sulfenic acids, which can be trapped and detected using either a variety of dimedone-based chemical probes ([@B111], [@B200]) or a genetically encoded probe that is based on the transcription factor Yap1, which usually interacts with the sulfenic acid of yeast glutathione peroxidase 3 (GPx3) ([@B267], [@B289]). Proteomic screens also revealed numerous sets of *S*-nitrosylated protein candidates, for example, from purified rat mitochondria ([@B49]), HEK293 cell cultures ([@B92]), mouse liver ([@B71]), or rat brain ([@B68], [@B133]). How *S*-nitrosothiols are generated *de novo* is an ongoing matter of debate ([@B175]). Furthermore, it is only known for a few of the *S*-nitrosylated protein candidates whether they can be transnitrosylated or reduced by GSH, Trx, or other thiol-containing proteins ([@B24], [@B95], [@B173], [@B175]). Because of the versatile chemistry of sulfenic acids and *S*-nitrosylated thiols, the experimental conditions---for example, the reduction of *S*-nitrosothiols with ascorbate---could be even more critical than for thiol/disulfide couples and may result in false-positive candidates ([@B237]).

Established metabolites and substrates {#s006}
--------------------------------------

### Reactive oxygen and nitrogen species {#s007}

Established electrophiles that are considered to play a role in glutathione metabolism can be subdivided according to their source. It is usually easier to determine the spatiotemporal distribution of electrophiles with an enzymatic source. Nonenzymatic protein, lipid, and metabolite radicals are, for example, supposed to be randomly formed, whereas extracellular or phagosomal superoxide anion (O~2~^•−^) is generated by membrane-bound NADPH oxidases ([@B21]). Other flavoenzymes can also produce O~2~^•−^ and hydroperoxide (H~2~O~2~) *in vitro* ([@B178], [@B179]) and it often remains to be shown which flavoenzyme significantly contributes to the production of both electrophiles in the cytosol, nucleus, mitochondria, peroxisomes, the endoplasmic reticulum, or at the plasma membrane. For instance, the flavins in complex I of bovine heart mitochondria as well as NADH dehydrogenase II and sulfite reductase in *Escherichia coli* were reported to be the major sources of O~2~^•−^ or H~2~O~2~ for these electron transport chains ([@B126], [@B154], [@B186]). However, the contribution of the latter two enzymes for the total generation of H~2~O~2~ in *E. coli* could be rather insignificant compared to autoxidation processes of soluble flavoenzymes ([@B126]). A recent study in yeast likewise indicates that cytosolic H~2~O~2~ levels do not depend on autoxidation processes of the mitochondrial respiratory chain, whereas changes in cytosolic H~2~O~2~ also affect the H~2~O~2~ levels in the mitochondrial matrix ([@B193]). Other sources for H~2~O~2~ than flavoenzymes are cytosolic and mitochondrial superoxide dismutases ([@B43], [@B125]). Nitrogen monoxide (NO^•^) is produced by NO synthases and reacts nonenzymatically with O~2~^•−^ to form peroxynitrite (ONOO^−^) ([@B38], [@B81]).

### Modified cysteine residues {#s008}

Both H~2~O~2~ and ONOOH can oxidize the thiol/selenol group of reactive cysteine/selenocysteine residues to sulfenic/selenenic acid ([@B35], [@B38], [@B60], [@B113], [@B238], [@B273]). Proteins with such reactive residues include thiol-dependent hydroperoxidases of the GPx and the peroxiredoxin (Prx) family ([Table 1](#T1){ref-type="table"}), which form extremely short-lived sulfenic/selenenic acids that are in some isoforms preferentially reduced by GSH ([@B35], [@B60], [@B89], [@B109], [@B261], [@B273]). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a well-established example for a nonhydroperoxidase protein with a physiologically relevant cysteine residue that is susceptible to sulfenic acid formation, *S*-nitrosothiolation, and reduction by GSH ([@B120], [@B225]). Protein *S*-nitrosylation and denitrosylation of a reactive cysteine residue have also been studied intensely for selected caspases but appear to rather depend on the Trx and not the glutathione system as reviewed previously ([@B24], [@B175]).

Protein disulfide bonds with extremely variable half-lives are formed in the cytosol, endoplasmic reticulum, mitochondrial intermembrane space, and bacterial periplasm by ribonucleotide reductase, 3′-phosphoadenosine 5′-phosphosulfate reductase, GPx and Prx, flavoenzymes such as Ero1 and Erv1, as well as ubichinon-dependent DsbB. These substrates and processes have been extensively reviewed before ([@B34], [@B36], [@B64], [@B65], [@B78], [@B95], [@B115], [@B149], [@B163], [@B187], [@B204], [@B238], [@B239], [@B273]). Nonetheless, it is not always clear whether the disulfide bond formation or reduction depends on glutathione and several surprises might be ahead of us. One lesson learnt from ribonucleotide reductase in mammals and *E. coli* is that the overlap of the Trx and glutathione system can differ among organisms ([@B301]). Another lesson learnt from oxidative protein folding in mitochondria is that glutathione may also interfere with processes that were not necessarily considered to be a part of the glutathione puzzle: The formation of disulfide bonds in the intermembrane space of mitochondria was demonstrated to be catalyzed by the concerted action of Mia40 and Erv1 ([@B185]), which suffice to reconstitute a functional oxidoreductase system *in vitro* ([@B269]). It was only later that GSH, in combination with Grx, was shown to affect and potentially regulate the redox state of Mia40 and oxidative protein folding *in vitro* and *in vivo* ([@B26], [@B150], [@B151]). Then again, processes that were thought to be glutathione dependent often lack experimental evidence. For example, for most thiol/disulfide substrates in the endoplasmic reticulum, it remains to be shown which substrate is processed by which protein disulfide isomerase (PDI) and whether this process really depends on GSH and/or GSSG *in vivo* ([@B8], [@B170], [@B209]).

Another modification of cysteine residues is iron--sulfur cluster binding. Protein-bound iron--sulfur clusters are assembled in the mitochondrial matrix, the chloroplast, or the cytosol. They are also found in the nucleus where they contribute to iron sensing as well as DNA replication and repair ([@B17], [@B56], [@B94], [@B153], [@B194], [@B214], [@B241]). Some of these iron--sulfur clusters form a complex with the cysteine residues of glutathione and Grx. Such clusters can be transferred to other proteins or result in altered protein--protein interactions ([@B17], [@B56], [@B164], [@B194], [@B214]). At this point, it is interesting to note that the oxidative damage of selected iron-containing proteins appears to be the detrimental key event when *E. coli* is treated with oxidants, because crucial enzymes are inactivated and reactive iron ions, O~2~^•−^ or H~2~O~2~, are liberated ([@B126], [@B145]). Even though iron metabolism of eukaryotes, particularly of animals, is much more complex ([@B75], [@B118]), the integration of the cellular iron and redox status also depends on a labile iron--sulfur cluster, namely cytosolic aconitase/iron regulatory protein 1. Thus, similar biochemical principles likely apply to oxidative challenges in *E. coli* and eukaryotes. This hypothesis is also supported by kinetic data on the reactivity of iron--sulfur clusters *in vitro* ([@B40], [@B86], [@B116]) and genetic studies on iron metabolism in yeast ([@B153], [@B194], [@B241], [@B285]). Please note that the initial damage of a rather small number of susceptible (iron-containing) proteins is in contrast to common theories on oxidative stress, which predict a general accumulation of damaged proteins as well as protein sulfenic acids and disulfides (see also the [Glutathione concentrations and Applications and Examples](#s012){ref-type="sec"} sections).

### Anabolites and toxic xenobiotics and catabolites {#s009}

Little is known about the intracellular spatiotemporal distribution of 2-oxoaldehydes, which can damage proteins and nucleic acids and are linked to numerous pathophysiological conditions ([@B85], [@B213], [@B232], [@B271]). These electrophiles are detoxified by Glo1 and Glo2 using GSH as a coenzyme ([Table 1](#T1){ref-type="table"}) ([@B60], [@B129], [@B270]). Because of the relevance of glucose-derived methylglyoxal, it is usually assumed that 2-oxoaldehydes are formed in the cytosol from where they can also diffuse into the nucleus. However, the exact repertoire and distribution of 2-oxoaldehydes in different organelles have not been mapped so far. Regarding the formation of the electrophilic lipid peroxidation product 4-hydroxy-2-nonenal, several studies have addressed the plasma membrane, the endoplasmic reticulum, or the inner mitochondrial membrane ([@B45], [@B257]), whereas no data seem to exist on other membranes and compartments \[*e.g*., peroxisomes, although the activation of peroxisome proliferator-activated receptors by 4-hydroxy-2-nonenal is well established ([@B51])\]. Advances in mass spectrometry might be suited to shed some light on this topic ([@B257]).

The turnover of the remaining electrophiles in [Figure 1](#f1){ref-type="fig"} depends on the cell type and localization of the corresponding GST or MAPEG isoform. For example, the detoxification of xenobiotics in the liver or in plant roots depends on a whole set of compartment-specific GST isoforms ([@B30], [@B60], [@B117]). Furthermore, you will look in vain for prostaglandin H metabolism in yeast as opposed to GST S1-1-containing mast cells ([@B278]) or prostaglandin E synthase-containing seminal glands ([@B205]). Likewise, the GST A3-3-dependent isomerization of Δ^5^-androstene-3,17-dione will not take place in erythrocytes in contrast to gonads and adrenal glands ([@B138]). Thus, caution is advised when general statements about the (ir)relevance of glutathione metabolism are made.

Summary I: metabolite and substrate repertoires {#s010}
-----------------------------------------------

The current picture of the compartment-specific glutathione metabolism is all but complete. In addition to well-characterized enzyme/electrophile couples, there are many orphan proteins that point to unknown metabolites and substrates, for example, in mitochondria, plastids, or the secretory pathway. Advances in mass spectrometry and the development of chemical and genetically encoded probes have recently led to the identification of numerous candidate proteins with glutathione or non-glutathione disulfide bonds, sulfenic acids, or *S*-nitrosothiols. Many of these candidate proteins have to be studied in more detail to exclude false-positive hits and to investigate if and how they are connected to glutathione metabolism. Even for established electrophiles and glutathione itself, the subcellular distribution and transport across membranes are often nebulous and remain to be unraveled.

Metabolite and Substrate Concentrations {#s011}
=======================================

Glutathione concentrations {#s012}
--------------------------

The concentration of GSH depends highly on the organism, cell type, and extra- or intrasubcellular compartment as reviewed previously ([@B60]). Estimated cytosolic GSH concentrations in yeast are 13 m*M* as opposed to "total" glutathione concentrations (*i.e*., GSH and GSSG) around 8 or 7 m*M* in mouse hybridoma or HeLa cells ([Fig. 2](#f2){ref-type="fig"}) ([@B124], [@B189], [@B212]). The GSH concentration in some bacteria such as *E. coli* could be as high as 20 m*M* ([@B180], [@B217]). Please note that there seems to be no reliable data on the overall concentration of all other glutathione-containing substances in [Figure 1](#f1){ref-type="fig"} (see also the [Electrophile Concentrations](#s013){ref-type="sec"} section). The real total glutathione concentration---including not only GSH and GSSG but also glutathionylated high- and low-molecular-weight thiols, hemithioacetals, thioesters, complexed iron--sulfur clusters, conjugated xenobiotics, GSOH, and GSNO *etc*.---is apparently unknown.

The endoplasmic reticulum of HeLa cells was reported to have an oxidizing half-cell reduction potential for GSH around −0.21 V and to contain a calculated concentration of more than 15 m*M* "total" glutathione ([@B27], [@B189]) \[see Refs. ([@B60], [@B87]) for a discussion of the half-cell reduction potential *E*′~GSH~\]. Based on previous GSH and GSSG import experiments with microsomal fractions ([@B18]), the authors therefore suggested that GSH is imported into the endoplasmic reticulum where it is trapped as GSSG ([Fig. 2](#f2){ref-type="fig"}) ([@B189]). The elegance of this model is that two processes, namely GSH oxidation and GSSG reduction, become uncoupled because of a spatial separation and deviating enzyme repertoires. This model is in clear contrast to a previous study suggesting the import of GSSG into the endoplasmic reticulum ([@B124]). How and to which degree GSH and GSSG are transported across the endoplasmic reticulum is of fundamental relevance for our understanding of oxidative protein folding ([@B36]) and is, therefore, also a hot topic in yeast cell biology ([@B272]).

Regarding basal GSSG concentrations outside the endoplasmic reticulum, noninvasive redox measurements with genetically encoded fluorescent probes revealed in a variety of organisms that the cytosol, the nucleus, peroxisomes, and mitochondria are extremely reducing environments with *E*′~GSH~ values between −0.30 and −0.32 V, which translate into nanomolar GSSG concentrations ([@B248]). For example, a calculated concentration around 0.2 μ*M* GSSG was estimated for the cytosol in yeast ([@B192]). If GR is so efficient to maintain 99.99% of "total" glutathione in a reduced state, why do so many cells and subcellular compartments contain so much glutathione? A commonly used argument is that GSH and thiol-containing proteins nonenzymatically buffer H~2~O~2~ and other hydroperoxides. However, as emphasized previously ([@B87], [@B90], [@B273]), such an explanation is based on an extremely unfavorable kinetic competition with hydroperoxidases. We will evaluate this competition as an example at the end of the review once we have gathered the missing parameters.

Deletion of GR in yeast resulted in an increase of the cytosolic GSSG concentration of only about one order of magnitude to ∼2--3 μ*M*. Excess GSSG (\>99%) was transported into the vacuole so that the cytosol remained a highly reducing compartment ([Fig. 2](#f2){ref-type="fig"}). A rapid ABC transporter-mediated export into the vacuole was also observed for wild-type yeast cells that were challenged with oxidants ([@B192]). Whether the export of GSSG on oxidative challenge is a common principle in biology still needs to be tested. Further documented examples include perfused rat liver and the bile duct ([@B1]) as well as astrocyte cell cultures ([@B122]). An export of GSSG from malaria parasites was also suggested ([@B12]) but was detected without thiol blocking agents in contrast to a subsequent study that revealed the export of GSH ([@B19]).

A rapid recovery of cytosolic *E*′~GSH~ values after oxidative challenge has been observed within seconds or a few minutes in a variety of cell types ([@B248]), only some of which contain a vacuole. The short-term disturbance of the redox state indicates a temporary change of metabolic flux and not a static accumulation of GSSG in contrast to false equilibrium-based assumptions as emphasized previously ([@B87]). Because the *de novo* synthesis of GSH cannot rapidly compensate altered *E*′~GSH~ values, the fast recovery has to be attributed to altered GSSG concentrations. There are four hypothetical competing scenarios for the rapid removal of GSSG after oxidative challenge: (i) ATP-driven export of GSSG as observed in yeast, (ii) rapid reduction of GSSG by GR as supported by *in vitro* kinetics and genetic experiments, (iii) enzymatic glutathionylation of proteins yielding RSSG and GSH, and (iv) nonenzymatic glutathionylation of proteins. We will try to evaluate this potential kinetic competition as an example at the end of the review (the [Kinetic Competitions for GSSG and GSSR](#s036){ref-type="sec"} section). The question on the intra- or extracellular fate of GSSG cannot be overemphasized because it is fundamental for the ongoing discussion on the origin of protein disulfide bonds and whether physiological challenges with oxidants results in a general protein oxidation and glutathionylation ([@B65], [@B87], [@B97], [@B252]).

Electrophile concentrations {#s013}
---------------------------

Even for the established metabolites and substrates in [Figure 1](#f1){ref-type="fig"}, there is rather limited or no information on their spatiotemporal distribution and compartment-specific concentration because of a lack of quantitative noninvasive detection methods (*e.g*., for xenobiotics in the cytosol, nucleus, mitochondria, peroxisomes, or endoplasmic reticulum). Some metabolites such as O~2~^•−^ or H~2~O~2~ can be measured *in situ* by chemical trapping ([@B43]) and/or by fluorescent dyes, but these probes lack specificity and are in most cases not ratiometric so that signals highly depend on the concentration of the probe ([@B293]). In contrast, genetically encoded H~2~O~2~ sensors that are based on redox-sensitive fluorescent proteins are ratiometric but also measure only changes instead of absolute concentrations ([@B248]). One noninvasive method for the quantitative detection of H~2~O~2~ was reported decades ago by Sies and colleagues and is based on the spectral properties of the catalase reaction intermediate "compound I" (see the [Differences Between Ping-Pong and Sequential Kinetic Patterns](#s030){ref-type="sec"} section) ([@B43], [@B211], [@B252], [@B253]). (Whether genetically encoded catalase in combination with different targeting sequences would allow the measurement of absolute H~2~O~2~ concentrations in a variety of organelles might be interesting to follow up.) Physiological steady-state concentrations of H~2~O~2~ in mammalian cells, yeast, and *E. coli* were also calculated using formation and degradation kinetics. Estimated and calculated values appear to be rather low and range from 1 n*M* H~2~O~2~ at basal steady-state conditions to 0.5--0.7 μ*M* during nonlethal oxidative challenge ([@B43], [@B193], [@B211], [@B249], [@B263]). A basal steady-state concentration around 1 n*M* was also calculated for ONOO^−^ ([@B38], [@B81]). The concentration of O~2~^•−^ in *E. coli* could be as low as 0.2 n*M*, which translates into only 0.1 molecules per cell but does not reflect the extreme metabolic flux, that is, the continuous rapid formation and removal of O~2~^•−^ ([@B104], [@B126], [@B127]). Models on human erythrocytes suggested even lower steady-state concentrations of H~2~O~2~ and O~2~^•−^ around 50 pM and 0.5 pM, respectively ([@B140]).

Other metabolites, such as 2-oxoaldehydes, glutathione esters, and eicosanoids, are often detected with or without derivatization after cell lysis ([@B217], [@B233], [@B288]). These invasive methods cannot discriminate between subcellular compartments because of extensive sample homogenization before the quantitative analysis, for example, by high-performance liquid chromatography or mass spectrometry ([@B288]). Nevertheless, calculated 2-oxoaldehyde concentrations in mammalian cells were reported to vary between 0.1 and 1 μ*M* for glyoxal and between 0.5 and 5 μ*M* for methyglyoxal ([@B232], [@B233]). A similar steady-state concentration of 4 μ*M* was modeled for methylglyoxal in yeast ([@B177]). Methylglyoxal is converted to *S*-[d]{.smallcaps}-lactoylglutathione ([@B60], [@B256], [@B270]). The calculated physiological steady-state concentration of this hemithioacetal in *E. coli* was lower than 50 μ*M* and shown to only increase above this value when cells were treated with exogenous methylglyoxal ([@B217]). Human leukemia cells were reported to contain 59 pmol *S*-[d]{.smallcaps}-lactoylglutathione per 10^6^ cells ([@B181]), which roughly translates into a concentration around 0.1 m*M* based on an estimated cytosol volume of 0.5 pl.

Optimized protocols to overcome disadvantages of invasive methods have been developed for the ratiometric detection of protein disulfides. For example, the physiological redox state can be "frozen" and labeled with alkylating agents before quantification by Western blotting, autoradiography, or mass spectrometry ([@B84], [@B160], [@B254], [@B296]). The concentration of a protein in its thiol and disulfide form might be subsequently estimated from the signal ratio, provided there is sufficient information on protein localization, molecule number per cell, and the corresponding compartment volume ([Table 2](#T2){ref-type="table"}). A similar arithmetical approach can be used to estimate the concentration of specific iron--sulfur cluster-containing proteins if there are data from activity assays or radioactive iron-labeling and immunoprecipitation experiments ([@B194], [@B241]). For example, activity measurements in *E. coli* revealed for aconitase-bound iron--sulfur clusters a calculated concentration around 10 μ*M* ([@B145]).

###### 

[Estimated Concentrations of Redox- and Glutathione-Dependent Enzymes in Yeast]{.smallcaps}

                                                                                                                                           *Estimated concentration*^[a](#tf8){ref-type="table-fn"}^               
  ------------- ---------------------------------------------------------------------------------- --------------------------------------- ----------------------------------------------------------- ----------- -----------
  GR/*GLR1*     No^[b](#tf9){ref-type="table-fn"}^ ([@B106], [@B153], [@B192], [@B195], [@B216])   Cyt, Nu?, MM ([@B215])                  0.44 μ*M*                                                   1.5 μ*M*    18 n*M*
  Grx1/*GRX1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B72], [@B73], [@B151], [@B168], [@B192])     Cyt, Nu?                                0.18 μ*M*                                                   6.5 μ*M*    27 n*M*
  Grx2/*GRX2*   No^[b](#tf9){ref-type="table-fn"}^ ([@B72], [@B73], [@B168], [@B192], [@B240])     Cyt, MM, IMS ([@B151], [@B223])         2.1 μ*M*                                                    2.3 μ*M*    3.4 n*M*
  Grx3/*GRX3*   No^[b](#tf9){ref-type="table-fn"}^ ([@B194], [@B231], [@B240])                     Cyt, Nu ([@B188])                       0.65 μ*M*                                                   0.30 μ*M*   6.8 n*M*
  Grx4/*GRX4*   No^[b](#tf9){ref-type="table-fn"}^ ([@B194], [@B231], [@B240])                     Cyt, Nu ([@B166])                       0.46 μ*M*                                                   0.14 μ*M*   ---
  Grx5/*GRX5*   No^[b](#tf9){ref-type="table-fn"}^ ([@B240], [@B241])                              MM ([@B241])                            10 μ*M*                                                     17 μ*M*     0.5 μ*M*
  Grx6/*GRX6*   No ([@B132], [@B184])                                                              ER and *cis*-Golgi ([@B132], [@B184])   3.9 μ*M*                                                    4.1 μ*M*    0.19 μ*M*
  Grx7/*GRX7*   No ([@B132], [@B184])                                                              *cis*-Golgi ([@B132], [@B184])          ---                                                         35 μ*M*     0.38 μ*M*
  Grx8/*GRX8*   No ([@B73])                                                                        Cyt ([@B123])                           40 n*M*                                                     0.16 μ*M*   ---
  Gto1/*GTO1*   No ([@B20])                                                                        Per ([@B20])                            ---                                                         ---         ---
  Gto2/*GTO2*   No^[b](#tf9){ref-type="table-fn"}^ ([@B20])                                        Cyt ([@B20])                            0.12 μ*M*                                                   37 n*M*     ---
  Gto3/*GTO3*   No^[b](#tf9){ref-type="table-fn"}^ ([@B20])                                        Cyt ([@B20])                            ---                                                         ---         ---
  Gtt1/*GTT1*   No ([@B20], [@B47], [@B52])                                                        ER-associated ([@B47])                  ---                                                         0.74 μ*M*   ---
  Gtt2/*GTT2*   No^[b](#tf9){ref-type="table-fn"}^ ([@B20], [@B47], [@B52])                        ?                                       ---                                                         ---         ---
  Ure2/*URE2*   No^[b](#tf9){ref-type="table-fn"}^ ([@B292])                                       Cyt ([@B74])                            0.49 μ*M*                                                   71 n*M*     14 n*M*
  TR1/*TRR1*    No^[b](#tf9){ref-type="table-fn"}^ ([@B274])                                       Cyt                                     20 μ*M*                                                     4.2 μ*M*    0.12 μ*M*
  TR2/*TRR2*    No^[b](#tf9){ref-type="table-fn"}^ ([@B221])                                       MM ([@B221])                            0.69 μ*M*                                                   0.94 μ*M*   ---
  Trx1/*TRX1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B72], [@B274])                               Cyt                                     0.59 μ*M*                                                   17 μ*M*     69 n*M*
  Trx2/*TRX2*   No^[b](#tf9){ref-type="table-fn"}^ ([@B72], [@B274])                               MM                                      1.2 μ*M*                                                    7.0 μ*M*    0.16 μ*M*
  Trx3/*TRX3*   No ([@B221])                                                                       MM ([@B221])                            1.7 μ*M*                                                    25 μ*M*     ---
  GPx1/*GPX1*   No ([@B14], [@B208])                                                               Per ([@B208])                           ---                                                         1.3 μ*M*    ---
  GPx2/*GPX2*   No ([@B14], [@B130])                                                               Cyt, Nu? ([@B123])                      0.12 μ*M*                                                   1.2 μ*M*    24 n*M*
  GPx3/*GPX3*   No^[b](#tf9){ref-type="table-fn"}^ ([@B14], [@B59], [@B130])                       Cyt ([@B123])                           0.56 μ*M*                                                   2.3 μ*M*    9 n*M*
  Tsa1/*TSA1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B42], [@B219], [@B298])                      Cyt ([@B219])                           26 μ*M*                                                     12 μ*M*     0.51 μ*M*
  Tsa2/*TSA2*   No^[b](#tf9){ref-type="table-fn"}^ ([@B219], [@B298])                              Cyt ([@B219])                           0.33 μ*M*                                                   0.18 μ*M*   ---
  Ahp1/*AHP1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B157], [@B219], [@B298])                     Cyt ([@B219])                           1.1 μ*M*                                                    31 μ*M*     1.3 μ*M*
  nTPx/*DOT5*   No ([@B41], [@B219], [@B298])                                                      Nu ([@B219])                            0.76 μ*M*                                                   1.7 μ*M*    17 n*M*
  mTPx/*PRX1*   No ([@B109], [@B219], [@B222], [@B298])                                            MM ([@B219])                            7.5 μ*M*                                                    30 μ*M*     0.18 μ*M*
  Cta1/*CTA1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B50], [@B107], [@B227])                      Per, MM ([@B227])                       0.69 μ*M*                                                   ---         ---
  Ctt1/*CTT1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B50], [@B107], [@B227])                      Cyt ([@B123])                           22 n*M*                                                     0.13 μ*M*   ---
  Sod1/*SOD1*   No^[b](#tf9){ref-type="table-fn"}^ ([@B25], [@B285])                               Cyt, Nu, IMS ([@B265])                  31 μ*M*                                                     71 μ*M*     0.23 μ*M*
  Glo1/*GLO1*   No ([@B128])                                                                       Cyt                                     0.18 μ*M*                                                   0.56 μ*M*   ---
  Glo2/*GLO2*   No ([@B29])                                                                        Cyt ([@B29])                            0.95 μ*M*                                                   0.53 μ*M*   26 n*M*
  Glo4/*GLO4*   No ([@B29])                                                                        MM ([@B29])                             ---                                                         0.18 μ*M*   ---
  ADH5/*ADH5*   No                                                                                 Cyt ([@B123])                           0.58 μ*M*                                                   0.71 μ*M*   23 n*M*

The concentration was calculated based on protein abundances from Refs. ([@B48], [@B100], [@B152]) as summarized in the Saccharomyces Genome Database ([www.yeastgenome.org](www.yeastgenome.org)). Molecules per cell were divided by the Avogadro constant and the estimated compartment volume. Averaged cell and organelle volumes are based on Ref. ([@B277]): whole cell, 50 fl (μm^3^); cytosol, 25 fl; nucleus, 4 fl; vacuole, 4fl; mitochondria, 1 fl; endoplasmic reticulum, 0.5 fl; peroxisomes, 0.5 fl; *cis*-Golgi, 0.2 fl. Compartment volumes were combined for dual localized proteins.

Combined gene deletions resulted in synthetic lethality.

Cyt, cytosol; ER, endoplasmic reticulum; IMS, mitochondrial intermembrane space; Nu, nucleus; MM, mitochondrial matrix; Per, peroxisomes.

Summary II: metabolite and substrate concentrations {#s014}
---------------------------------------------------

Basal cytosolic concentrations of H~2~O~2~ and GSSG are probably in the nanomolar concentration range in contrast to low micromolar methylglyoxal concentrations and millimolar GSH concentrations. The compartment-specific concentrations of most of the potential and established electrophiles in [Figure 1](#f1){ref-type="fig"} as well as the concentrations of glutathione conjugates often remain to be determined. This is also the case for NADPH and the extracytosolic concentrations of GSH and GSSG. The development of novel, preferentially noninvasive metabolomic methods is therefore crucial for our understanding of glutathione metabolism. However, how do substrate concentrations affect the glutathione metabolism? To answer this question, we will have to consider some aspects in enzymology.

The Relevance of Kinetic Constants {#s015}
==================================

Difference between true and apparent *k*~cat~ and *K*~m~ values {#s016}
---------------------------------------------------------------

Enzymes are characterized by their kinetic constants, the *k*~cat~ and *K*~m~ values, as exemplified in [Eq. 2](#eq4){ref-type="tex-math"} ([@B28], [@B250]). The true *k*~cat~ value or turnover number of an enzyme indicates how many molecules of substrate are metabolized by a single enzyme molecule per second at saturating substrate concentrations (mol~substrate~ × mol~enzyme~^−1^ × s^−1^). Thus, the SI unit of the *k*~cat~ value is "s^−1^". If an enzyme uses more than one substrate, which is the case for most of the enzymes in [Table 1](#T1){ref-type="table"} that catalyze a glutathione-dependent conversion of an electrophile, the reaction rate can also depend on more than one substrate concentration. Using the Cleland notation, reaction 3 describes a general ping-pong mechanism with two substrates and two products, a covalently modified enzyme species "F" as a reaction intermediate, and the two enzyme--substrate complexes "ES~A~" and "FS~B~". Several of the reactions in [Table 1](#T1){ref-type="table"} can be described by this or very similar schemes. (However, there are also glutathione-dependent enzymes that catalyze sequential instead of ping-pong reactions, *e.g*., many GST and MAPEG isoforms.)

![](inl-1){#f9}

Enzyme species "E" can only react with the first substrate and species "F" can only react with the second substrate. Thus, the substrates never encounter each other and the reaction can be subdivided into two half-reactions, which is a perfect mechanism to kinetically uncouple two processes (as outlined in the Molecular Lego: Uncoupling Mechanisms Using Modular Enzymes section). If the initial reaction velocity *ν*~0~ is determined and no backward reaction takes place, the half-reactions can be described by sequence 4a and 4b. $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
[ { \rm { E } } ] + [ { { \rm { S } } _ { \rm { A } } } ] \mathrel
{ \mathop { \kern0pt\rightleftharpoons } \limits_ { { k_ { - 1 } }
} ^ { { k_1 } } } [ { \rm { ES } } ] \xrightarrow{k_2}  [ { \rm {
F } } ] + [ { \rm { P } } ] \tag {4{\rm a}}
\end{align*}
\end{document}$$ $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
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[ { \rm{F}} ] + [ {{ \rm{S}}_{ \rm{B}}} ]
\mathrel{\mathop{\kern0pt\rightleftharpoons}\limits_{{k_{-
3}}}^{{k_3}}} [ { \rm{FS}} ] \xrightarrow{k_4}  [ { \rm{E}} ] + [
{ \rm{Q}} ] \tag{4{\rm b}}
\end{align*}
\end{document}$$ $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
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\frac { 1 }  { { { v_0 } } } = { \frac { { K_ { { \rm { mA } } } }
}  { { V_ { \max } } } } \frac { 1 }  { { [ { { \rm { S } } _ {
\rm { A } } } ] } } + { \frac { { K_ { { \rm { mB } } } } }  { {
V_ { \max } } } } \frac { 1 }  { { [ { { \rm { S } } _ { \rm { B }
} } ] } } + \frac { 1 }  { { { V_ { \max } } } } \tag {{\rm eq.
3}}
\end{align*}
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 { K_ { { \rm { mA } } } } = { \frac { { k_ { - 1 } } + { k_2 } }  { { k_1 } } } \ { K_ { { \rm { mB } } } } = { \frac { { k_ { - 3 } } + { k_4 } }  { { k_3 } } }
\end{align*}
\end{document}$$

The rate equation for reaction 4 is best to grasp in its double reciprocal form ([Eq. 3](#f9){ref-type="fig"}). The term 1/\[S~B~\] can be neglected at a very high concentration of the second substrate so that the kinetic relevance of reaction 4a is analyzed (because the enzyme is predominantly present as species "E"). The same is true at a very high concentration of the first substrate and the analysis of the kinetic relevance of species "F" and reaction 4b. Under these conditions, [Eq. 3](#f9){ref-type="fig"} is mathematically identical to the double reciprocal form of [Eq. 2](#eq4){ref-type="tex-math"} and the *k*~cat~ value can be theoretically calculated from the maximum reaction velocity (*k*~cat~ = *V*~max~/\[E\]). However, enzyme kinetics often cannot be measured at such high substrate concentrations. The obtained constant is therefore an apparent *k*~cat~ value (*k*~cat~^app^) at a defined nonsaturating substrate concentration as exemplified for the ping-pong kinetics in [Figure 3A](#f3){ref-type="fig"}. The true *k*~cat~ value is usually extrapolated from a number of *k*~cat~^app^ values using a so-called secondary plot ([@B28], [@B250]), as shown in [Figure 3B](#f3){ref-type="fig"}. Please note that the true *k*~cat~ value can be a combination of the rate constants *k*~2~ and *k*~4~ of reaction 4, provided they are rate limiting. This is, however, not necessarily the case as outlined below.

![**Effect of variable substrate concentrations on GSH-dependent enzyme kinetics.** In this example, the enzyme "E" uses a ping-pong mechanism to convert the electrophilic substrate "S." The shown patterns are typical for Grx-catalyzed reductions of glutathionylated disulfide substrates, yielding a thiol and GSSG (GSH + RSSG→RSH + GSSG). Similar patterns are found for selected GPx or Prx that catalyze the GSH-dependent reduction of hydroperoxides. **(A)** The normalized reaction rates for variable concentrations of "S" at four different constant concentrations of GSH are plotted directly according to the Michaelis--Menten theory (*left panel*) and in double reciprocal form according to the Lineweaver--Burk theory (*right panel*). The data can be usually fitted using the Michaelis--Menten equation (with *k*~cat~^app^ and *K*~m~^app^ values replacing *k*~cat~ and *K*~m~ as shown in [Eq. 2](#eq4){ref-type="tex-math"}), yielding hyperbolic and linear curves in the direct and double reciprocal plot, respectively. The parallel lines in the Lineweaver--Burk plot are indicative for the ping-pong mechanism with the constant slope *K*~m~^app^/*k*~cat~^app^. **(B)** The apparent kinetic parameters at different GSH concentrations from panel A are analyzed in a (double reciprocal) secondary plot. Linear fits for enzymes with infinite *k*~cat~ and *K*~m~ value pass through the origin (enzyme A). The true *K*~m~ and *k*~cat~ value of other enzymes can be calculated from the x- and y-axis intercepts, respectively (enzyme B). The reciprocal slope of the linear fit corresponds to a second-order rate constant *k*~2~, in this case for the reaction between the glutathionylated enzyme "F" and GSH.](fig-3){#f3}

The *K*~m~ value is the substrate concentration at which the half-maximum reaction rate is reached. The unit of the *K*~m~ value is "*M*". Changes of substrate concentrations below the *K*~m~ value have a more drastic impact on the reaction rate than altered substrate concentrations far above the *K*~m~ value (*e.g*., the change of the reaction rate between 0 and 0.5 m*M* substrate in [Figure 3A](#f3){ref-type="fig"} is much larger than the change between 1.5 and 2 m*M* substrate). Hence, it is important to know the physiological substrate concentration to estimate its effect on the reaction rate of a specific enzyme--substrate couple. Apparent *K*~m~ values (*K*~m~^app^) are obtained if another substrate is present at a nonsaturating concentration (or if the pH value or a salt concentration is not optimal). *K*~m~ and *K*~m~^app^ values can reflect the affinity of an enzyme for its substrate. This is the case when the conversion of the enzyme--substrate complex to product is much slower than the unproductive dissociation of the complex. In other words, a lower *K*~mA~ value indicates a higher affinity for the first substrate of reaction 4, provided that *k*~2~ is much smaller than *k*~-1~ (*K*~m~ ∼ *k~-~*~1~/*k*~1~). The same is true for the second substrate, provided that *k*~4~ is much smaller than *k*~-3~ ([@B28], [@B250]).

Infinite *k*~cat~ and *K*~m~ values {#s017}
-----------------------------------

The two enzyme--substrate complexes "ES~A~" and "FS~B~" are supposed to accumulate in scheme 3 and to reach a steady-state concentration according to the classical Michaelis--Menten theory. However, many glutathione-dependent enzymes, including several hydroperoxidases and Grx, have infinite true *k*~cat~ and *K*~m~ values and cannot be saturated even at very high substrate concentrations ([Fig. 3B](#f3){ref-type="fig"}) ([@B23], [@B69], [@B89], [@B96], [@B97], [@B108], [@B224], [@B273], [@B300]). In mathematical terms, these enzymes can be defined by unusual steady-state concentrations of "ES~A~" and "FS~B~" that tend to be zero. Dalziel established for such kinetics an elegant version of [Eq. 3](#f9){ref-type="fig"} ([Eq. 4](#eq10){ref-type="tex-math"}) ([@B57]), which can be used to describe the kinetics of many GPx and Prx as well as some Grx ([@B22], [@B89], [@B90], [@B273]). In this version, *k*~A~ and *k*~B~ are the rate constants of both half-reactions. (Using *V*~max~ = *k*~cat~\[E\], [Eq. 4](#eq10){ref-type="tex-math"} can be derived from [Eq. 3](#f9){ref-type="fig"} by multiplication with \[E\] so that the terms *K*~m~\[E\]/*k*~cat~\[E\] are reduced to the kinetic constants *k*~A~^−1^ and *k*~B~^−1^. The term 1/*V*~max~ in [Eq. 3](#f9){ref-type="fig"} is zero in this special case because of the infinite *k*~cat~ value.) $$\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\usepackage{upgreek}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
 { \frac { [ { \rm { E } } ] }  { { v_0 } } } = \frac { 1 }  { {
{ k_ { \rm { A } } } [ { { \rm { S } } _ { \rm { A } } } ] } } +
\frac { 1 }  { { { k_ { \rm { B } } } [ { { \rm { S } } _ { \rm {
B } } } ] } } \tag {{\rm eq. 4}}
\end{align*}
\end{document}$$

Two mechanistic scenarios for infinite *k*~cat~ and *K*~m~ values have been previously discussed for the oxidative and reductive half-reactions of GPx, Prx, and Grx ([@B90], [@B97], [@B273]). (i) Rate constants *k*~2~ and *k*~4~ in reaction 4 are not rate limiting. This is the case when the enzyme and substrate form a very short-lived complex with such an optimized interaction that the product is immediately formed once the substrate is bound. If the half-reactions are irreversible, *k*~A~ and *k*~B~ in [Eq. 4](#eq10){ref-type="tex-math"} are identical to the second-order rate constants *k*~1~ and *k*~3~ of reaction 4a and 4b, respectively (see also the [Second-Order Rate Constants](#s018){ref-type="sec"} section). (ii) There is no enzyme--substrate complex that can accumulate in accordance with the classical Michaelis--Menten theory, because there is no enzyme--substrate interaction except for the catalytic event as shown in scheme 5 ([@B57], [@B97], [@B273]).

![](inl-2){#f10}

Scenarios (i) and (ii) with and without an enzyme--substrate complex can be discriminated using substrate analogs and products that could act as inhibitors. Absence of an inhibition points to the absence of an enzyme--substrate complex as previously emphasized for Grx catalysis ([@B97]). The oxidative half-reaction of GPx and Prx---that is, the irreversible reduction of hydroperoxides---probably occurs without a real enzyme--substrate complex, which makes sense considering the size of H~2~O~2~ and the rapid turnover of structurally diverse hydroperoxide substrates ([@B35], [@B89], [@B273]). The reversible reduction of glutathionylated substrates by Grx was also suggested to occur without an enzyme--substrate complex ([@B97]) because many Grx are poorly inhibited by *S*-methylglutathione or [l]{.smallcaps}-γ-glutamyl-[l]{.smallcaps}-α-aminobutyrylglycine (ophthalmic acid) ([@B22], [@B96], [@B97], [@B258], [@B268]). Nevertheless, Grx require two distinct glutathione interaction sites for catalysis ([@B22]), and several partially conserved residues ([@B22], [@B60]) presumably confer specificity for the γ-glutamyl moieties of the glutathione disulfide substrate (GSSR) and GSH substrate ([@B77], [@B224], [@B234], [@B258]). The situation is similar to the reductive half-reaction of glutathione-dependent GPx, which have partially conserved glutathione-binding sites but are poorly inhibited by GSSG ([@B60], [@B88], [@B273]). For oxidized GPx, an enzyme--substrate complex is supposed to be formed ([@B273]). A hit-and-run mechanism involving specific glutathione-interacting residues was also suggested for Glo2, which works with a sequential Theorell-Chance and not a ping-pong mechanism ([@B60], [@B280]).

Regardless of the true mechanism of these glutathione-dependent enzymes, it is important to note that even enzymes with infinite true *k*~cat~ and *K*~m~ values can have an apparent saturation behavior ([Fig. 3A](#f3){ref-type="fig"}). This becomes understandable considering that enzymes with a ping-pong mechanism alternate between species "E" and "F" as shown in scheme 3. If one substrate is present at a limiting concentration, only a fraction of the enzyme becomes available for the other substrate resulting in an apparent saturation. What are the implications regarding the interpretation of apparent *K*~m~ and *k*~cat~ values? The interpretation of *K*~m~^app^ and *k*~cat~^app^ of enzymes with infinite kinetic parameters depends on the investigated protein and requires thorough kinetic analyses at different substrate and inhibitor concentrations. As recently shown in a comparative study on wild-type and mutant Grx from yeast and *Plasmodium falciparum* ([@B22]), lowering the concentration of the first substrate lowered the *K*~m~^app^ value for the second substrate because of a decreased steady-state concentration of species "F" (and not because of a higher substrate affinity). Likewise, the *k*~cat~^app^ value was lowered reflecting that fewer molecules of species "F" were available for the turnover of the second substrate. Please note that the ratio *k*~cat~^app^/*K*~m~^app^ is correlated with the second-order rate constant of the reaction and should therefore remain constant (as outlined in the [Second-Order Rate Constants](#s018){ref-type="sec"} section and illustrated by the parallel lines in the Lineweaver--Burk plot in [Fig. 3A](#f3){ref-type="fig"}).

Second-order rate constants {#s018}
---------------------------

Infinite true *k*~cat~ and *K*~m~ values provide rather limited information on the reactivity of a catalyst. They are sometimes detected for extremely efficient catalysts as well as for lousy enzyme--substrate couples (*e.g*., when the wrong substrate is analyzed *in vitro*). Enzymes with infinite true *k*~cat~ and *K*~m~ values, such as many GPx, Prx, or Grx, are therefore often characterized by their second-order rate constant or by their *k*~cat~^app^ and *K*~m~^app^ values. For the second-order rate constant, enzyme and substrate are treated as regular chemicals that react in a bimolecular elementary reaction according to [Eq. 1](#eq3){ref-type="tex-math"}. The value for *k*~2~ in [Eq. 1](#eq3){ref-type="tex-math"} (or *k*~A~ according to [Eq. 4](#eq10){ref-type="tex-math"}) can be determined from the reciprocal slope of secondary plots ([Fig. 3B](#f3){ref-type="fig"}). Similar values are often obtained for the catalytic efficiency (*k*~cat~^app^/*K*~m~^app^). Please note that the Michaelis--Menten [Eq. 2](#eq4){ref-type="tex-math"} can be simplified for \[S\] \<\< *K*~m~, yielding a rate equation that is, from a mathematical point of view, identical to [Eq. 1](#eq3){ref-type="tex-math"} (*k*~cat~^app^/*K*~m~^app^* = k*~2~).

The second-order rate constant *k*~2~ and the catalytic efficiency have the unit "*M*^−1^s^−1^" and are highly suited to directly compare the reactivity of potentially competing molecules. Some of the values used in the Applications and Examples section are listed in [Table 3](#T3){ref-type="table"}. For example, the second-order rate constant for the reaction between superoxide dismutase and O~2~^•−^ is ∼2 × 10^9^ *M*^−1^s^−1^, which is about 10 million times faster than the second-order rate constant for the nonenzymatic reaction between GSH and O~2~^•−^ around 200 *M*^−1^s^−1^ ([@B82], [@B142]). Likewise, second-order rate constants for the reaction between hydroperoxidases and H~2~O~2~ are often between 10^5^ and 10^7^ *M*^−1^s^−1^, which is again up to 10 million times faster than the second-order rate constant for the nonenzymatic reaction between GSH and H~2~O~2~ around 1 *M*^−1^s^−1^ ([@B35], [@B273], [@B275], [@B295]). It is important to note that the rate constant of GSH is similar to other low-molecular-weight thiols ([@B295]). Even the active site cysteines of Trx and other enyzmes have similar second-order rate constants ([@B235], [@B263]). One exception to the slow sulfenic acid formation in nonhydroperoxidases is the redox-sensitive cysteine residue of GAPDH with an intermediate rate constant of 100 *M*^−1^s^−1^ at pH 7 and 0°C ([@B165]). The higher reactivity of GAPDH depends on the protonation of the generated hydroxyl ion, which is a very poor leaving group ([@B225]). The latter property explains the relative stability of H~2~O~2~ and its low reactivity with other enzymes that contain a cysteine thiolate residue \[see Refs. ([@B34], [@B91], [@B111], [@B263]) for further rate constants of protein thiols\]. Thus, taking only the rate constants into account, superoxide dismutases and hydroperoxidases clearly outcompete the cysteine residues of GSH or regular proteins for the reduction of O~2~^•−^ or H~2~O~2~ ([@B34], [@B91], [@B142], [@B263], [@B294]). The kinetics of these established electrophiles provides good examples for the relevance of rate constants. At this point it is important to note that rate constants, for example, of disulfides and sulfenic acids, can be extremely variable and depend on multiple factors such as the protein environment ([@B60], [@B65], [@B111], [@B198], [@B201]). Furthermore, even when the rate constants of potentially competing reactions have been determined, they are not sufficient to judge a competition as outlined in The Relevance of the Enzyme Concentration section.

###### 

[Selected Rate Constants and Catalytic Efficiencies]{.smallcaps}

  *Reaction*                                                    *Catalyst?*            *Rate constant or* k~cat~^app^/K~m~^app^*value*   *Reference*
  ------------------------------------------------------------- ---------------------- ------------------------------------------------- ----------------------------
  GSH + O~2~^•−^ + H^+^→GS^•^ + H~2~O~2~                        Nonenzymatic           ∼200 *M*^−1^s^−1^                                 ([@B142])
  2 O~2~^•−^ + 2 H^+^→O~2~ + H~2~O~2~                           Nonenzymatic           2 × 10^5^*M*^−1^s^−1^                             ([@B93])
  2 O~2~^•−^ + 2 H^+^→O~2~ + H~2~O~2~                           Superoxide dismutase   2 × 10^9^*M*^−1^s^−1^                             ([@B82])
  GS^•^ + NO^•^/NO~2~^•^/GS^−^→GSNO/NO~2~/SG^•−^                Nonenzymatic           ∼10^9^*M*^−1^s^−1^                                ([@B38], [@B147])
  GSH + H~2~O~2~→GSOH + H~2~O                                   Nonenzymatic           0.87 *M*^−1^s^−1^                                 ([@B295])
  GSH + H~2~O~2~→GSOH + H~2~O                                   Ure2                   84 *M*^−1^s^−1^                                   ([@B16])
  GAPDH~red~ + H~2~O~2~→GAPDH~ox~ + H~2~O                       GAPDH                  ∼(2--11) × 10^2^*M*^−1^s^−1^                      ([@B165])
  Grx~red~ + H~2~O~2~→Grx~ox~ + H~2~O                           mGrx2                  7.7 × 10^3^*M*^−1^s^−1^                           ([@B80])
  Grx~red~ + H~2~O~2~→Grx~ox~ + H~2~O                           hGrx2                  2.5 × 10^4^*M*^−1^s^−1^                           ([@B80])
  Grx~red~ + H~2~O~2~→Grx~ox~ + H~2~O                           ScGrx1                 5.3 × 10^4^*M*^−1^s^−1^                           ([@B52])
  Grx~red~ + H~2~O~2~→Grx~ox~ + H~2~O                           ScGrx2                 2.6 × 10^4^*M*^−1^s^−1^                           ([@B52])
  Prx~red~ + H~2~O~2~→Prx~ox~ + H~2~O                           Tsa1                   2.2 × 10^7^*M*^−1^s^−1^                           ([@B207])
  Prx~red~ + H~2~O~2~→Prx~ox~ + H~2~O                           Tsa2                   1.3 × 10^7^*M*^−1^s^−1^                           ([@B207])
  GPx~red~ + H~2~O~2~→GPx~ox~ + H~2~O                           Mammalian GPx1/3       (4--5) × 10^7^*M*^−1^s^−1^                        ([@B89], [@B273])
  Prx~red~ + H~2~O~2~→Prx~ox~ + H~2~O                           Prx2                   10^8^*M*^−1^s^−1^                                 ([@B174])
  GSH + HSA(SOH)→HSA(SSG) + H~2~O                               Nonenzymatic           2.9 *M*^−1^s^−1^                                  ([@B276])
  Cys(SH) + Cys(SOH)→CysSSCys + H~2~O                           Nonenzymatic           \>10^5^*M*^−1^s^−1^                               ([@B199])
  2 GSH + GPx(SeOH)→GPx(SeH) + GSSG                             Mammalian GPx1/3/4     (0.6--4) × 10^5^*M*^−1^s^−1^                      ([@B273])
  Trx~red~ + GPx/Prx(SOH)→GPx/Prx(SH) + Trx~ox~                 Other GPx              ∼10^4^−10^6^*M*^−1^s^−1^                          ([@B273])
  LMW(SH) + RSSG→LMW(SSG) + RSH                                 Nonenzymatic           0.01--200 *M*^−1^s^−1^                            ([@B23], [@B198], [@B266])
  Grx(SH) + Cys(SSG)→Grx(SSG) + Cys                             hGrx1                  7.0 × 10^5^*M*^−1^s^−1^                           ([@B96])
  GSH + Grx(SSG)→Grx(SH) + GSSG                                 hGrx1                  9.9 × 10^4^*M*^−1^s^−1^                           ([@B96])
  Grx(SH) + Cys(SSG)→Grx(SSG) + Cys                             hGrx2                  1.0 × 10^5^*M*^−1^s^−1^                           ([@B96])
  GSH + Grx(SSG)→Grx(SH) + GSSG                                 hGrx2                  6.3 × 10^3^*M*^−1^s^−1^                           ([@B96])
  Grx(SH) + BSA(SSG)→Grx(SSG) + BSA                             PtGrxS12               8.0 × 10^5^*M*^−1^s^−1^                           ([@B300])
  GSH + Grx(SSG)→Grx(SH) + GSSG                                 PtGrxS12               2.5 × 10^4^*M*^−1^s^−1^                           ([@B300])
  Grx(SH) + GSSG→Grx(SSG) + GSH                                 SsGrx1                 7.1 × 10^5^*M*^−1^s^−1^                           ([@B234])
  Grx(SH) + Cys(SSG)→Grx(SSG) + Cys                             ScGrx7                 (7.3--9.7) × 10^5^*M*^−1^s^−1^                    ([@B22])
  GSH + Grx(SSG)→Grx(SH) + GSSG                                 ScGrx7                 (2.5--4.7) × 10^5^*M*^−1^s^−1^                    ([@B22])
  Grx(SH) + Cys(SSG)→Grx(SSG) + Cys                             PfGrx^C32S/C88S^       1.4 × 10^6^*M*^−1^s^−1^                           ([@B22])
  GSH + Grx(SSG)→Grx(SH) + GSSG                                 PfGrx^C32S/C88S^       1.2 × 10^5^*M*^−1^s^−1^                           ([@B22])
  Fd + Grx\[2Fe~2~S~2~(GS)~2~\]→Fd\[2Fe~2~S~2~\] + Grx +2 GSH   PtGrxS14               3.3 × 10^2^*M*^−1^s^−1^                           ([@B17])

Summary III: the relevance of kinetic constants {#s019}
-----------------------------------------------

Second-order rate constants and *k*~cat~^app^/*K*~m~^app^ values are highly suited to directly compare the reactivity of enzymes and other potentially competing molecules. *K*~m~^app^ and *k*~cat~^app^ values are useful to estimate the rate of an enzyme-catalyzed reaction under physiological conditions, for example, at nonsaturating substrate concentrations. Even enzymes with infinite true *k*~cat~ and *K*~m~ values can have an apparent saturation behavior. To compare potentially competing reactions, we have to know both, the physiological substrate concentrations and the kinetic constants.

The Relevance of the Enzyme Repertoire {#s020}
======================================

Within the past decades, the localization of numerous glutathione-dependent enzymes has been determined in a variety of organisms. Thus, it is well known in which subcellular compartment most of these proteins are ([Table 2](#T2){ref-type="table"}), although dual protein targeting complicates the situation and seems to be a quite common feature in glutathione metabolism ([@B35], [@B55], [@B60], [@B70], [@B144], [@B171], [@B191], [@B215], [@B223]). However, there are still some blind spots and missing pieces. These include glutathione transporters ([Fig. 2](#f2){ref-type="fig"}) as well as the tissue- and organelle-specific distribution of several of the Grx and GST isoforms in plants and animals.

Many low-molecular-weight electrophiles such as disulfides, hydroperoxides, and xenobiotics are metabolized by seemingly redundant enzymes within a single organism. Some of the redundancy can be explained by overlapping but nonidentical substrate preferences or by the compartmentalization of eukaryotic cells. However, even prokaryotes as well as selected compartments of eukaryotes harbor multiple enzymes with similar or identical substrate preferences. I will illustrate this again for the hydroperoxidases, simply because there is much more information on these enzymes than on the other proteins that are listed in [Table 1](#T1){ref-type="table"}. Three major families of hydroperoxidases (GPx, Prx, and catalases) are found in parallel in many prokaryotic and eukaryotic cells. These enzymes have deviating properties and can be further subdivided into a variety of isoforms ([Fig. 4](#f4){ref-type="fig"}) ([@B35], [@B60], [@B113], [@B202], [@B273]). The cytosol of yeast, for example, contains the catalase Ctt1, the Prx isoforms Tsa1, Tsa2, and Ahp1, as well as the GPx isoforms GPx2 and GPx3 ([Table 2](#T2){ref-type="table"}). Among the thiol-dependent hydroperoxidases, selenocysteine-containing mammalian GPx are the most reactive enzymes with second-order rate constants for H~2~O~2~ \> 10^7^ *M*^−1^s^−1^ ([@B35], [@B89], [@B273]). In contrast, cysteine-containing GPx and Prx---only some of which use GSH as an electron donor ([@B60], [@B69], [@B83], [@B273])---have rate constants that often range from 10^4^ to 10^7^ *M*^−1^s^−1^ ([@B35], [@B273], [@B275], [@B294]). Heme-containing catalases have rate constants \>10^7^ *M*^−1^s^−1^ but are thiol independent and catalyze the disproportionation reaction 2 H~2~O~2~→O~2~ + 2 H~2~O ([@B3], [@B31], [@B202], [@B206]). Please note that the reaction rates of peroxidases are usually linear at low nanomolar substrate concentrations and can be described by [Eq. 1](#eq3){ref-type="tex-math"} (\[S\] \<\< *K*~m~, [Second-Order Rate Constants](#s018){ref-type="sec"} section). Some 1-Cys Prx isoforms, however, might be even inactivated at such low H~2~O~2~ concentrations, which would explain why they are inactive in standard enzymatic assays *in vitro* ([@B62], [@B66], [@B203]). Why do many organisms possess members of all three major hydroperoxidase families in a single compartment? Furthermore, what is the benefit or function of less efficient Prx isoforms?

![**Comparison of normalized hydroperoxidase activities at variable H~2~O~2~ concentrations.** Normalized reaction rates at **(A)** high, **(B)** intermediate, and **(C)** low H~2~O~2~ concentrations are shown from *left* to *right*. Kinetic parameters for equine catalase (*k* = 3.5 × 10^7^ *M*^−1^s^−1^), bovine GPx1 at 4 m*M* GSH (*k*~cat~^app^ = 3 × 10^3^ s^−1^, *K*~m~^app^ = 3 × 10^−5^ *M*), and recombinant peroxiredoxin AhpC from *Salmonella typhimurium* (*k*~cat~^app^ = 52 s^−1^, *K*~m~^app^ = 1.4 × 10^−6^ *M*) are based on reported measurements by Ogura ([@B206]), Flohe *et al.* ([@B89]), and Parsonage *et al.* ([@B220]), respectively. The parameters for the modeled sensitive Prx isoform are *k*~cat~^app^ = 100 s^−1^ and *K*~m~^app^ = 1 × 10^−5^ *M*.](fig-4){#f4}

Alternative substrate concentrations and preferences {#s021}
----------------------------------------------------

A comparison of the normalized reaction rates and *K*~m~^app^~(H2O2)~ values of GPx, Prx, and catalases suggests the following physiological implications. Catalases are excellent catalysts at all substrate concentrations. They have an advantage at peak concentrations of H~2~O~2~ above 50 μ*M* because of an absent substrate saturation ([Fig. 4A](#f4){ref-type="fig"}). However, whether this is of physiological relevance is questionable for many organisms (as outlined in the Electrophile Concentrations section). Selenocysteine-containing GPx are the most active hydroperoxidases at H~2~O~2~ concentrations below 50 μ*M*, whereas some cysteine-containing GPx and Prx have similar activities as catalases at H~2~O~2~ concentrations ≤ 0.1 μ*M* ([Fig. 4B, C](#f4){ref-type="fig"}). Thus, a broad hydroperoxidase repertoire might reflect an adaptation to variable H~2~O~2~ concentrations, for example, in pathogenic organisms that have to compensate basal H~2~O~2~ concentrations as well as short-term peak concentrations because of plant or animal host defense mechanisms.

Even though members of all three hydroperoxidase families convert H~2~O~2~ as an oxidizing substrate, they utilize different reducing agents. Catalases have the advantage that they do not rely on the NADPH-dependent replenishment of thiol pools and that the demand for reducing equivalents is coupled to its supply (because H~2~O~2~ is the electron acceptor and donor). The combination of GPx and Prx might allow a balanced consumption of electrons from different thiol pools, for example, from the GSH and Trx pool. Please note that although many Prx and GPx are specific for their electron donor, several isoforms appear to be more promiscuous and accept electrons from Trx, Grx, and/or GSH ([@B60], [@B66], [@B69], [@B83], [@B236], [@B242], [@B261], [@B273]). The thiol-dependent hydroperoxidases also have deviating preferences regarding the oxidizing substrate. For example, monomeric mammalian GPx4 reduces membrane-bound lipid hydroperoxides in contrast to the soluble tetrameric GPx homologues ([@B35]).

Redox sensing and moonlighting functions {#s022}
----------------------------------------

Another explanation for the variety of cellular hydroperoxidases is that some GPx and Prx are H~2~O~2~ sensors, which allow a fine-tuned redox regulation. As reviewed previously, these proteins are inactivated at higher hydroperoxide concentrations or form mixed protein--protein disulfide bonds with intermediate half-lives for signal transduction ([@B34], [@B46], [@B59], [@B65], [@B110], [@B131], [@B137], [@B238], [@B255], [@B299]). Last but not least, hydroperoxidases can also exert moonlighting functions, for example, as chaperones or for sperm maturation ([@B39], [@B136], [@B282]).

Summary IV: relevance of the enzyme repertoire {#s023}
----------------------------------------------

Seemingly redundant enzyme repertoires can result in kinetic competitions. The repertoires originate from many factors, including the compartmentalization of eukaryotic cells, overlapping but nonidentical substrate preferences, an adaptation to variable substrate concentrations and electron donors, as well as alternative (moonlighting) functions, for example, in redox signaling or protein folding. These factors have been intensely studied for peroxidases and are presumably also important for Grx, GST, glyoxalases, and other glutathione-dependent enzymes, even though their physiological functions often remain to be characterized ([Table 1](#T1){ref-type="table"}) ([@B60], [@B65], [@B279]). Thus, to understand glutathione metabolism, it is crucial to determine the compartment-specific enzyme repertoires and to assign a function to each member of these highly diverse protein families.

The Relevance of the Enzyme Concentration {#s024}
=========================================

Turnover numbers and second-order rate constants of redox enzymes differ by several orders of magnitude. However, just because an enzyme is much less reactive does not mean that it is irrelevant. I will first illustrate this again for the hydroperoxidases and subsequently discuss the implications for other proteins and for common genetic approaches.

Hydroperoxidase concentrations {#s025}
------------------------------

Based on the normalized reaction rates in [Figure 4A and B](#f4){ref-type="fig"}, one might assume that some Prx play a rather minor role for the detoxification of H~2~O~2~ compared to catalase and selenocysteine-containing GPx. However, if we consider the physiological concentration of H~2~O~2~ in the nanomolar (or maybe picomolar) concentration range, which is usually far below the *K*~m~^app^ value, the differences between the peroxidases are less pronounced ([Fig. 5A](#f5){ref-type="fig"}). If we now take into account that many Prx are among the most abundant proteins (top 5%) in many eu- and prokaryotes ([@B287]), the lower activity compared to catalase is more than compensated ([Fig. 5B, C](#f5){ref-type="fig"}). For example, deficiencies of catalase or GPx1 in mouse erythrocytes were reported to result in rather mild phenotypes in contrast to the loss of Prx2, which caused hemolytic anemia ([@B159]). The latter phenotype and the significant contribution of Prx2 to H~2~O~2~ removal ([@B140], [@B159]) become explainable considering that Prx2 has an estimated concentration of 0.24 m*M* in erythrocytes ([@B190]). (However, additional Prx2-specific functions, for example, in redox signaling or hemoglobin stabilization ([@B46], [@B114], [@B299]), could also contribute to the phenotype.) [Figure 5B and C](#f5){ref-type="fig"} also reveals how an enzyme with a high second-order rate constant can become completely irrelevant if competing enzymes are much more concentrated in the same compartment. Please note that such deviating concentrations are not unusual for redox enzymes. For instance, a ratio of ∼1200:1 was reported for the yeast peroxiredoxin Tsa1 and the cytosolic catalase Ctt1 ([@B100]). Based on a cytosol volume of roughly 50 fl, the data translate into estimated concentrations of Tsa1 and Ctt1 around 25 μ*M* and 20 n*M*, respectively ([Table 2](#T2){ref-type="table"}). This scenario is similar to the one for protein A and C in [Figure 5C](#f5){ref-type="fig"}. Thus, the comparison of reaction rates taken alone can be misleading.

![**Variable enzyme concentrations have drastic effects on reaction rates.** Reaction rates for hypothetical hydroperoxidases A--D are shown from *left* to *right* at three different enzyme concentrations and variable H~2~O~2~ concentrations. The kinetic parameters of enzymes A--D are identical to the enzymes in [Figure 4](#f4){ref-type="fig"}. The relevance of each enzyme is depicted below each plot. **(A)** Model with an identical concentration of 1 μ*M* for all four proteins. **(B)** Model with enzyme concentrations differing by two orders of magnitude. **(C)** Model with enzyme concentrations differing by four orders of magnitude. Similar enzyme concentrations are found in [Table 2](#T2){ref-type="table"}.](fig-5){#f5}

Implications for other enzymes {#s026}
------------------------------

Effects of variable reactivities and concentrations also apply to other potentially competing glutathione-dependent enzymes such as Grx or GST isoforms. It is therefore important to determine not only the presence and kinetic constants of these enzymes but also their compartment-specific concentrations using the same approaches as outlined for the protein substrates (Electrophile Concentrations section). Activity measurements of Glo1 and Glo2 in *E. coli* revealed, for example, calculated concentrations around 0.6 and 3 μ*M*, respectively ([@B217]). A nice example for the compartment-specific distribution of an enzyme in eukaryotes is Cu/Zn-superoxide dismutase, which was determined for rat hepatocytes by quantitative immunocytochemistry ([@B44]): The highest amount of the enzyme was found in the cytosol and nucleus, whereas highest estimated concentrations were detected in lysosomes (42 and 22 μ*M vs.* 240 μ*M*, respectively). Peroxisomes contained lower concentrations of superoxide dismutase around 8 μ*M* and the secretory pathway was (almost) devoid of the enzyme ([@B44]). Complementing approaches were also developed for the quantification of catalase and GPx ([@B291]). Thus, it is, in principle, possible to obtain reasonable estimates for compartment-specific enzyme concentrations. The situation for multicellular organisms is of course further complicated because of tissue-specific differences as highlighted in the mouse "redox atlas" ([@B103]). One advantage of yeast as a model organism is the availability of quantitative data on protein abundances. A major drawback is, however, that data sets can differ by up to two orders of magnitude ([Table 2](#T2){ref-type="table"}) ([@B48], [@B100], [@B152]). These differences presumably originate from alternative quantification methods using the fluorescence intensity of C-terminally GFP-tagged proteins ([@B48]), Western blot signals of C-terminally TAP-tagged proteins ([@B100]), or mass spectrometry signals from untagged peptides ([@B152]).

Implications for genetic approaches {#s027}
-----------------------------------

An often neglected aspect regarding enzyme concentrations is that the scenarios in [Figure 5B and C](#f5){ref-type="fig"} do not occur only under normal growth conditions. Such scenarios are also artificially generated by reverse genetics, for example, by gene deletions or complementation studies with high copy number plasmids or strong promoters. Such tools are commonly used to aggravate a metabolic imbalance---for example, on the addition of highly concentrated electrophiles---to trigger pronounced growth defects or a rescue phenotype. This is certainly a great approach to gain first insights on the potential function of a protein *in vivo*. However, it may also lead to an over- or underestimated relevance of an enzyme or might even result in an incorrect functional assignment. If, for example, candidate peroxidase A only rescues a knockout strain of peroxidase B on H~2~O~2~ treatment when protein A is about a hundred times more abundant than under normal growth conditions---*e.g.*, using a high copy number plasmid for expression---then it is not necessarily justified to conclude that protein A is important for the removal of H~2~O~2~. Likewise, some phenotypes might require the deletion of another gene. For example, the comparison of two peroxidase candidates A and B might only reveal an interesting phenotype for a strain that lacks the major peroxidase C. Such experiments might rather point to the irrelevance of candidates A or B compared to peroxidase C but are sometimes used to promote a novel function *in vivo* (see also the [Kinetic Competitions for hydroperoxides I: Grx and GST](#s034){ref-type="sec"} section).

Summary V: relevance of the enzyme concentration {#s028}
------------------------------------------------

The relevance of enzyme concentrations for the reaction rates of potentially competing processes can be easily underestimated. There are rather few examples for which we know reliable compartment-specific enzyme concentrations. Much more data are required to quantify potential kinetic competitions. Furthermore, genetic approaches that are commonly used to address the relevance of glutathione-dependent processes require sufficient controls to avoid incorrect functional assignments because of altered enzyme concentrations.

The Relevance of Enzymatic Mechanisms and Kinetic Patterns {#s029}
==========================================================

Differences between ping-pong and sequential kinetic patterns {#s030}
-------------------------------------------------------------

Kinetic patterns of glutathione-dependent enzymes depend on the substrates and the catalytic mechanisms. These can differ drastically among the protein families in [Table 1](#T1){ref-type="table"} ([@B60]). Enzymes with two substrates often have either ping-pong or sequential kinetic patterns ([@B28], [@B250]). Both kinetic patterns are easily distinguished in Lineweaver--Burk plots as depicted in [Figure 6](#f6){ref-type="fig"}. The patterns are not always predictable and have to be determined experimentally for each enzyme--substrate couple. A sequential pattern usually indicates a ternary complex between the enzyme and both substrates. However, ping-pong mechanisms can also result in sequential kinetic patterns, for example, when a substrate or product acts as an inhibitor ([@B28], [@B250]). In contrast to the glutathionylated substrates of Grx ([Fig. 6A](#f6){ref-type="fig"}), this seems to be the case for the non-glutathione model substrate bis(2-hydroxyethyl)disulfide (HEDS) ([Fig. 6B](#f6){ref-type="fig"}): Grx reduces HEDS enzymatically ([@B23]) yielding the mixed disulfide between GSH and 2-mercaptoethanol (GSSEtOH) as a product. GSSEtOH is subsequently utilized as a glutathionylated substrate in the same assay. However, newly formed GSSEtOH probably adopts a futile orientation at the enzyme and has to be released before it is accepted as a substrate ([@B22]). Thus, GSSEtOH also seems to act as an inhibitor that causes the sequential kinetic patterns. To which degree similar Grx-catalyzed reactions occur *in vivo* remains to be clarified. Potential non-glutathione substrates that might cause such kinetic patterns include [l]{.smallcaps}-cystine, coenzyme A disulfides or diallyl disulfides, and related compounds from garlic and other *Allium* species ([@B23]).

![**Kinetic patterns depend on the enzyme and substrate.** Lineweaver--Burk plots are shown for three different enzyme--substrate combinations. **(A)** Ping-pong patterns of ScGrx7 with the model substrate [l]{.smallcaps}-cysteine-glutathione disulfide (GSSCys) at three different GSH concentrations based on data from Ref. ([@B22]). The reciprocal slope (the *k*~cat~^app^/*K*~m~^app^ value) remains constant because an increase of the *k*~cat~^app^ value is coupled to an increase of the *K*~m~^app^ value. **(B)** Sequential kinetic patterns of ScGrx7 with the model substrate HEDS at three different GSH concentrations based on data from Ref. ([@B22]). The reciprocal slope (the *k*~cat~^app^/*K*~m~^app^ value) and the *k*~cat~^app^ values vary, whereas the *K*~m~^app^ values remain constant. **(C)** pH-dependent sequential kinetic patterns of PfGlo2 at four different concentrations of SLG based on data from Ref. ([@B280]). The reciprocal slope (the *k*~cat~^app^/*K*~m~^app^ value) and the *K*~m~^app^ values vary, whereas the *k*~cat~^app^ values remain constant. HEDS, bis(2-hydroxyethyl)disulfide; SLG, *S*-[d]{.smallcaps}-lactoylglutathione.](fig-6){#f6}

In addition to standard ping-pong or sequential patterns, Lineweaver--Burk plots are sometimes curved or biphasic. This can point to a glutathione-dependent allostery or cooperativity as revealed for a monomeric Glo1 isoform and a PrxV-type enzyme from malaria parasites ([@B67], [@B69], [@B261]). Classical heme-containing catalases use the following unusual ping-pong mechanism: reduction of the first H~2~O~2~ molecule yields the oxidized enzyme, an oxoferryl porphyrin cation radical termed "compound I". Oxidation of the second H~2~O~2~ molecule regenerates the Fe^3+^-containing enzyme ([@B3]). Because H~2~O~2~ is the substrate for both half-reactions, catalase cannot be saturated, resulting in a linear substrate concentration dependence of the reaction rate ([Fig. 4A](#f4){ref-type="fig"}). However, the physiological situation is more complicated because the enzyme gets inactivated by O~2~^•−^, and alternative electron donors such as ethanol compete for the reductive half-reaction of bifunctional catalase peroxidases ([@B43]). Further mechanisms of the enzymes in [Table 1](#T1){ref-type="table"} are reviewed in Ref. ([@B60]).

Why are the mechanisms and kinetic patterns important? An allostery or cooperativity points to a glutathione-dependent enzyme regulation. For example, glutathione was shown to alter the oligomerization, activity, and function of selected Prx *in vitro* ([@B69], [@B218], [@B226]). Furthermore, the second substrates of enzymes with ping-pong or sequential kinetic patterns have different effects on the kinetic parameters. (i) Decreasing the concentration of the second substrate of an enzyme with ping-pong patterns shifts the ratio between the enzyme species "E" and "F" in scheme 3 toward species "F" and results in lower *k*~cat~^app^ and *K*~m~^app^ values for the first substrate ([Fig. 6A](#f6){ref-type="fig"}). Different GSH concentrations in the cytosol and the endoplasmic reticulum should therefore alter the ratio between reduced and glutathionylated GPx isoforms in these compartments. (ii) In contrast, decreasing the concentration of the second substrate of an enzyme with sequential patterns results in lower *k*~cat~^app^ values and/or higher *K*~m~^app^ values ([Fig. 6B, C](#f6){ref-type="fig"}). Both effects cause a drop of the catalytic efficiency (the *k*~cat~^app^/*K*~m~^app^ value), whereas the efficiencies of enzymes with ping-pong patterns remain unaffected by the substrate concentration. The latter aspect might be helpful to decipher the physiological role of high GSH concentrations (Mother Nature Invented GSH: But Why So Much section).

Molecular Lego: uncoupling mechanisms using modular enzymes {#s031}
-----------------------------------------------------------

Why do pro- and eukaryotes contain so many catalytically inactive Grx isoforms that are involved in iron metabolism? How can some GPx and Prx isoforms exert additional functions as redox sensors? All these enzymes have in common that they utilize ping-pong mechanisms for catalysis. The selectivity of glutathione-dependent enzymes appears to depend on the geometric and electrostatic complementarity of the protein--substrate couple. In other words, the substrate and the transition state nicely fit into the active site of the protein, and the recruitment of the substrate in a suitable orientation is guided by the electrostatic surface potential ([@B22], [@B60], [@B65]). As outlined in the Difference Between True and Apparent *k*~cat~ and *K*~m~ Values section, substrates of enzymes with ping-pong mechanisms never encounter each other (scheme 3). Furthermore, the trigonal bipyramidal transition states during GPx, Prx, and Grx catalysis necessitate either drastic conformational changes or two distinct substrate interaction sites ([@B22], [@B60], [@B73]). These chemical constraints result in a modular enzyme architecture, which is even more pronounced in redox-active flavoenzymes such as GR, TrxR, or Erv ([@B60], [@B64]). Thus, point mutations in enzymes with ping-pong mechanisms can have a specific effect on only one of both half-reactions and enzyme--substrate interactions. This allows the utilization of alternative substrates or the deceleration or inactivation of a half-reaction to kinetically uncouple a process and to accumulate a metastable intermediate ([Fig. 7](#f7){ref-type="fig"}).

![**The modular architecture of enzymes with ping-pong mechanisms facilitates the gain of novel functions.** Two evolutionary scenarios are shown to illustrate how point mutations affect the geometric and electrostatic complementarity between the enzyme and substrate. For enzymes with ping-pong mechanisms, mutations can selectively alter the substrate preferences (scenario *a*) and/or kinetics (scenario *b*). This can result in trapped enzyme species and novel functions, for example, in redox signaling or iron--sulfur cluster biogenesis. The model may apply to all kinds of enzymes with ping-pong mechanisms such as Grx, Prx, GPx, GR, and TrxR \[see Ref. ([@B60]) for details on the respective enzyme mechanisms\]. Please note that the relevant enzyme--substrate interactions might be very temporary. Furthermore, they are not restricted to the reaction center and also include the protein surface that can affect the substrate recruitment.](fig-7){#f7}

Mutations and the spatiotemporal separation of the hydroperoxide reduction from the reductive half-reaction allowed Prx and GPx, for example, to switch between different reducing agents and to accumulate a metastable oxidized enzyme species for redox signaling ([@B59], [@B60], [@B113], [@B261], [@B273], [@B299]). A similar scenario was suggested for Grx catalysis ([@B60], [@B73]), which was recently shown to require two distinct glutathione interaction sites, one for GSSR and one for GSH ([Fig. 8](#f8){ref-type="fig"}) ([@B22]). In the course of evolution, mutations in the rather ill-defined GSH interaction site presumably abolished the enzymatic activity of most monothiol Grx isoforms. The mutations include the loss of a hydroxyl group of a conserved tyrosine residue and the introduction of a rigid proline and a bulky tryptophan residue ([Fig. 8](#f8){ref-type="fig"}) ([@B22], [@B60], [@B63], [@B183]). Loss of the GSH interaction resulted in a kinetic uncoupling from GSH catalysis and probably stabilized the interaction between glutathione and an iron--sulfur cluster at the GSSR binding site. The kinetic uncoupling from redox catalysis obviously allowed an important gain of function for Grx in iron metabolism ([@B17], [@B56], [@B163], [@B194], [@B214], [@B241]), which has been suggested to be, at least in yeast, the most relevant branch of glutathione metabolism ([@B153]). It may also allow GSSG sensing by monothiol Grx ([Kinetic Competitions for GSSG and GSSR](#s036){ref-type="sec"} section)

![**The modular architecture of enzymes with ping-pong mechanisms allows a kinetic uncoupling of the half-reactions.** Grx catalysis with glutathionylated substrates (GSSR) requires two distinct glutathione interaction sites because of the transition-state geometry of thiol/disulfide exchange reactions ([@B22], [@B60], [@B183]). The upper and lower parts illustrate differences and similarities between active and inactive Grx isoforms. Both groups have partially conserved residues for the interaction with the GSSR substrate at the so-called scaffold site. This interaction results in the glutathionylation of the active site cysteine residue. The scaffold site can also interact with glutathione that is bound to other groups (X) such as glutathione conjugates or iron--sulfur clusters ([@B161], [@B164], [@B183], [@B302]). Inactive Grx lack the hydroxyl group of a conserved tyrosine residue in a CxY(C/S)-motif and have a bulky WP-motif that probably interferes with the GSH interaction at a predominantly uncharacterized activator site ([@B22], [@B60], [@B63], [@B183]). Thus, the reductive half-reaction of inactive Grx is either very slow or cannot take place anymore because of an incompatible geometric and electrostatic complementarity between the enzyme and GSH ([@B22], [@B60], [@B65]).](fig-8){#f8}

Are there further candidates for molecular uncoupling mechanisms? Many dithiol and monothiol Grx isoforms have an additional, catalytically irrelevant cysteine residue after a GG motif ([@B60], [@B69]). The residue was shown to form a variety of mixed disulfide bonds *in vitro* ([@B69]). Such modifications could interfere with the GSSR interaction site and might uncouple the oxidative instead of the reductive half-reaction of Grx. This might shut off the deglutathionylation activity of Grx. An alternative inactivation of the oxidative half-reaction includes the phosphorylation of selected threonine or serine residues, as hypothesized previously ([@B97]). Please note that both reversible uncoupling scenarios might solve the dilemma how specific glutathionylated substrates should accumulate at high GSH concentrations in the presence of Grx ([Kinetic Competitions for GSSG and GSSR](#s036){ref-type="sec"} section).

Summary VI: relevance of enzymatic mechanisms and kinetic patterns {#s032}
------------------------------------------------------------------

The knowledge on enzyme mechanisms and kinetic patterns is crucial to estimate the physiological effects of altered substrate concentrations or inhibitors. Modular ping-pong reactions facilitate a molecular evolution that results in the use of alternative substrates and that allows a kinetic uncoupling of processes from redox catalysis at physiological GSH concentrations. Such processes include redox sensing, iron--sulfur cluster binding, and maybe protein glutathionylation and oxidative protein folding.

Applications and Examples {#s033}
=========================

Now that we have gained an overview on the relevant parameters and gathered some quantitative data, we can apply this information to estimate the reaction rates of potentially competing enzymatic as well as nonenzymatic reactions in glutathione metabolism. I will provide three examples to address (i) whether hydroperoxide detoxification is a common function of glutathione metabolism, (ii) whether GSSG-dependent glutathionylations occur during oxidative challenge, and (iii) whether GSH plays a role as a radical scavenger. The reader is encouraged to raise the question whether similar quantitative approaches might be helpful to address other aspects of glutathione metabolism, for example, using the data from [Tables 1--3](#T1 T2 T3){ref-type="table"}.

Kinetic competitions for hydroperoxides I: Grx and GST {#s034}
------------------------------------------------------

Which glutathione-dependent processes contribute to the detoxification of hydroperoxides and/or H~2~O~2~-dependent redox signaling? As reviewed previously, glutathione-dependent hydroperoxidases are rather the exception, and most characterized GPx and Prx isoforms were shown to use Trx isoforms as electron donors ([@B60], [@B90], [@B172], [@B273]). From an evolutionary perspective, this contradicts the hypothesis that high GSH concentrations are pivotal for the detoxification of hydroperoxides. To rescue the hypothesis, one might consider other ubiquitous glutathione-dependent proteins. A hydroperoxidase activity was indeed not only detected for selected GPx and Prx ([@B35], [@B60], [@B89], [@B109], [@B261], [@B273]) but also for several GST, MAPEG, and Grx isoforms ([@B16], [@B52], [@B53], [@B60], [@B80], [@B121], [@B134], [@B135], [@B229]). Are these *in vitro* activities high enough to become physiologically relevant, as has been suggested by independent groups based on survival and protection assays in yeast and human cell cultures ([@B52], [@B53], [@B80])?

Mammalian Grx2 as well as yeast ScGrx1 and ScGrx2 were reported to have quite high hydroperoxidase activities with *k*~cat~^app^/*K*~m~^app^ values for H~2~O~2~ ranging from 7.7 × 10^3^ to 5.3 × 10^4^ *M*^−1^s^−1^ ([Table 3](#T3){ref-type="table"}) ([@B52], [@B80]). Only one GSH concentration was tested for these enzymes so that we can only speculate on the kinetic patterns. For the sake of simplicity, we will assume ping-pong patterns with constant *k*~cat~^app^/*K*~m~^app^ values irrespective of the GSH concentration. Furthermore, we will assume that the *k*~cat~^app^/*K*~m~^app^ values really reflect the oxidative half-reaction and are comparable with the second-order rate constants of GPx and Prx. Estimated concentrations for cytosolic ScGrx1 and ScGrx2 range from 3.4 n*M* to 6.5 μ*M*. The estimated concentration of the competing cytosolic Prx isoform Tsa1 is between 0.51 and 26 μ*M* ([Table 2](#T2){ref-type="table"}). Second-order rate constants of Tsa1/2 for H~2~O~2~ are about 10^7^ *M*^−1^s^−1^ ([Table 3](#T3){ref-type="table"}) ([@B207]). To evaluate a competition at a theoretical H~2~O~2~ concentration of 10 n*M*, we will use the highest *k*~cat~^app^/*K*~m~^app^ value of Grx. Taking all these parameters into account, we can now estimate the reaction rates using [Eq. 1](#eq3){ref-type="tex-math"} ([Box 1](#box1){ref-type="boxed-text"}).

###### 

[Calculated Reaction Rates of Grx, Prx, and GPx at 10 n*M* H~2~O~2~]{.smallcaps}

*v*~Grx(high)~ = 5.3 × 10^4^ M^−1^s^−1^ × 6.5 μM × 10 nM = **3.4 × 10^−9^ M/s**

*v*~Grx(low)~ = 5.3 × 10^4^ M^−1^s^−1^ × 3.4 nM × 10 nM = **1.8 × 10^−12^ M/s**
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*v*~Tsa(high)~ = 10^7^ M^−1^s^−1^ × 26 μM × 10 nM = **2.6 × 10^−6^ M/s**

*v*~Tsa(low)~ = 10^7^ M^−1^s^−1^ × 0.5 μM × 10 nM = **5.0 × 10^−8^ M/s**

\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\-\--

*v*~GPx1~ = 4.7 × 10^7^ M^−1^s^−1^ × 1 μM × 10 nM = **4.7 × 10^−7^ M/s**

*v*~Prx2~ = 10^8^ M^−1^s^−1^ × 10 μM × 10 nM = **1.0 × 10^−5^ M/s**

The most optimistic scenario at a high Grx and low Tsa1 concentration suggests that the reaction rate of Grx accounts for 7% of the Tsa1 rate, which is still too slow for an efficient competition. If this scenario is correct, a fraction of Grx might, nonetheless, form a sulfenic acid and act as a redox sensor to explain the observed survival effects. However, redox sensing would require a kinetic uncoupling from the reduction by GSH, that is, a stabilization of the sulfenic acid or an efficient competition between GSH and a cysteine residue (Molecular Lego: Uncoupling Mechanisms Using Modular Enzymes section). For the most pessimistic scenario, the reaction rate of H~2~O~2~ with Grx is up to six orders of magnitude smaller than the rate with Tsa1. This scenario is quite likely considering that Tsa1 was reported to constitute 0.7% of the total soluble protein from yeast ([@B146]). Thus, the reaction of Grx with H~2~O~2~ is too slow to compete with the established hydroperoxidases in yeast.

Box 1 also shows calculated reaction rates for mammalian GPx1 and Prx2 using rate constants of 4.7 × 10^7^ *M*^−1^s^−1^ and 10^8^ *M*^−1^s^−1^ ([@B89], [@B174], [@B273]) as well as hypothetical protein concentrations of 1 and 10 μ*M*, respectively. The reaction rates at 10 n*M* H~2~O~2~ between 5 × 10^−7^ and 10^−5^ *M*/s are in the same range as for Tsa1 in yeast. This would explain why glutathione-dependent mammalian GPx isoforms can play a role in hydroperoxide removal, although there are certainly kinetic competitions with Prx and catalase depending on the substrate, the subcellular localization, and the enzyme concentration ([Fig. 5](#f5){ref-type="fig"}) ([@B35], [@B89], [@B273]). Regarding the moderate hydroperoxidase activity of mammalian Grx2 isoforms in [Table 3](#T3){ref-type="table"}, it appears unlikely that these enzymes are concentrated enough to compete with the established hydroperoxidases.

Which information is available on the potential relevance of GST in yeast? The cytosolic GST isoform Ure2 was reported to have a hydroperoxidase activity with sequential kinetic patterns ([@B16]). The *k*~cat~^app^/*K*~m~^app^ value at 1 m*M* GSH is about a hundred times higher than the second-order rate constant for the nonenzymatic H~2~O~2~-dependent formation of GSOH ([Table 3](#T3){ref-type="table"}). Considering an estimated concentration of Ure2 between 14 and 490 n*M* ([Table 2](#T2){ref-type="table"}), which is more than a thousand-fold lower than the GSH concentration, the Ure2-dependent reaction rate is not only negligible compared to Tsa1 but also much slower than the nonenzymatic reaction between H~2~O~2~ and GSH (which ranges from 10^−11^ to 10^−12^ *M*/s at 10 n*M* H~2~O~2~).

In summary, a physiological relevance of Grx and GST isoforms as hydroperoxidases is highly questionable, unless (i) there is a specific substrate, (ii) the compartment contains no classical hydroperoxidases, (iii) the enzyme is either very concentrated or directly targeted to the H~2~O~2~ source, or (iv) one of the assumptions above is completely wrong. Considering that the reported effects in yeast and human cell cultures required an overexpression of Grx ([@B52], [@B53], [@B80]), it is likely that the results are based on artificially high Grx concentrations (similar to shifting the relevance of enzyme A from [Fig. 5C or 5B to 5A](#f5){ref-type="fig"}). This interpretation is also supported by genetic and proteomic studies suggesting that the Trx/TrxR system is the major electron donor for the reduction of hydroperoxides in yeast ([@B153], [@B156]).

Kinetic competitions for hydroperoxides II: GAPDH {#s035}
-------------------------------------------------

What can we say about the formation of sulfenic acids in other proteins than GPx and Prx? As emphasized previously, there are only few cysteine residues with rate constants above 10^2^ *M*^−1^s^−1^ that might compete with the activity of hydroperoxidases ([@B34], [@B59], [@B65], [@B91], [@B263]). One exception is GAPDH ([Table 3](#T3){ref-type="table"}), which forms a sulfenic acid that is susceptible to the reduction by GSH ([@B111], [@B120], [@B225], [@B246], [@B251]). The extrapolation of the rate constant of GAPDH with H~2~O~2~ at 25°C depends on the activation energy. Using the Arrhenius equation, the rate constant from Ref. ([@B165]) at 0°C, and a hypothetical activation energy between 65 and 20 kJ/mol, reasonable estimates for the *k*~2~ value range from 200 to 1100 *M*^−1^s^−1^. Furthermore, GAPDH is one of the most abundant cytosolic proteins (top 5%) ([@B287]) and was suggested to have a concentration of up to 1 m*M* ([@B225]). Combining the information, the estimated reaction rate of GAPDH at 10 n*M* H~2~O~2~ is between 2 × 10^−9^ *M*/s and 1.1 × 10^−8^ *M*/s. A comparison with the reaction rates from Box 1 reveals for the most optimistic scenario---with a *k*~2~ value of 1100 *M*^−1^s^−1^ and an unrealistic low Tsa1 concentration---that the reaction rate of GAPDH is about 20% of the Tsa1 rate (or 2% of the reaction rate of GPx1 in mammals). If the concentration of GAPDH is lower, the *k*~2~ value is smaller, and/or the Tsa1 concentration is higher, less than 0.02% of H~2~O~2~ might react with GAPDH, which is more realistic. However, in contrast to GPx, Prx, and also Grx, the cysteine residue of GAPDH is quite buried, and the reduction by GSH is probably much slower than the reduction of the other proteins ([Table 3](#T3){ref-type="table"}). Thus, GAPDH(SOH) can accumulate over time and reach detectable steady-state concentrations ([@B111]). The accumulation of oxidized GAPDH was suggested to either affect moonlighting functions or to shift the metabolic flux of glucose toward the pentose phosphate pathway, yielding NADPH for the reduction of Trx and GSSG ([@B120], [@B225], [@B251]).

It remains highly controversial whether sulfenic acids of less abundant and reactive proteins accumulate *in vivo*. On the one hand, low nanomolar steady-state concentrations translate into only a handful of H~2~O~2~ molecules in subcellular compartments with a volume around 1 fl (see [Table 2](#T2){ref-type="table"} legend for estimated compartment volumes). If a highly reactive and abundant peroxidase is present, the chances of H~2~O~2~ to react with a common nonreactive cysteine residue are minuscule because of an unwinnable kinetic competition. Even for GAPDH, a rate constant of 1100 *M*^−1^s^−1^ at a steady-state concentration of H~2~O~2~ around 10 n*M* translates into a half-time for sulfenic acid formation of 12 h. In other words, it would require 12 h (or 15 min at 0.5 μ*M* H~2~O~2~) to oxidize 50% of GAPDH, provided that the sulfenic acid is not reduced again. In the same time, only 0.04% of a regular cysteine residue with a rate constant of 1 *M*^−1^s^−1^ would become oxidized, and it would take about 12 days at 10 n*M* H~2~O~2~ until 1% of the oxidized protein accumulates (always provided that the sulfenic acid is not reduced again). This also shows that even compartments without highly concentrated peroxidases will only accumulate sulfenic acids very slowly as long as the H~2~O~2~ concentration does not rise. The only way to accelerate the reaction is to either alter the rate constant, for example, by increasing the pH or by increasing the (local) H~2~O~2~ concentration. The latter scenario might occur *in vivo* when H~2~O~2~ is generated in the proximity of a cysteine residue, for example, by a flavoenzyme or a damaged iron--sulfur cluster. These conditions would increase the likelihood for a successful sulfenic acid formation. However, even that is not enough to result in the accumulation of sulfenic acids at steady-state conditions. For this, the reduction of the sulfenic acid has to be slow. Reported rate constants for the *in vitro* reduction of sulfenic acids depend on the protein environment and range from 0.012 to \>10^5^ *M*^−1^s^−1^ ([Table 3](#T3){ref-type="table"}) ([@B111], [@B199]).

In summary, a general accumulation of sulfenic acids cannot occur *in vivo*. The formation of specific sulfenic acids requires unusual conditions such as (i) high (local) hydroperoxide concentrations, (ii) the absence of competing hydroperoxidases, or (iii) a very reactive cysteine residue in combination with a high protein concentration. Except for GAPDH, the bacterial transcription factor OxyR, and maybe a few other candidates, it is questionable whether sulfenic acids of nonhydroperoxidases are formed to a significant extent *in vivo* ([@B34], [@B65], [@B91]). The steady-state concentration of such species depends not only on the oxidation but also on the reduction rate, both of which are usually unknown.

Kinetic competitions for GSSG and GSSR {#s036}
--------------------------------------

A reiterated model of diverse theories on oxidative stress is that protein cysteine residues are protected from "overoxidation" by unspecific glutathionylations. Such theories are sometimes supported by proteomic screens revealing hundreds of glutathionylated candidates ([@B143]). Glutathionylated residues are suggested to be formed from (i) sulfenic acids and GSH, from (ii) thiols that react with accumulated GSSG, from (iii) nitrosothiols, or (iv) from radicals \[see Ref. ([@B95]) for review\]. Another way to obtain a glutathionylated protein is of course the reaction between a protein disulfide bond and GSH, however, it is not really plausible why the initial disulfide bond should be less protected under oxidative challenge than the mixed disulfide bond with glutathione. The promiscuous formation of sulfenic acids under oxidative challenge is implausible and can be discarded as a general glutathionylation mechanism (Kinetic competitions for hydroperoxides II: GAPDH section). Radical reactions are discussed in the Kinetic Competitions for Radicals section. We will therefore continue with potential nonenzymatic and enzymatic competitions for GSSG.

Cytosolic Grx are, because of their ping-pong mechanism, supposed to be predominantly present in the reduced state at physiological GSH concentrations. No apparent substrate saturation is expected at nanomolar or low micromolar GSSG concentrations (in analogy to the hydroperoxidases shown in [Fig. 5](#f5){ref-type="fig"}). The concentration of enzymatically active mammalian Grx is ∼1 μ*M* in the cytosol and in the mitochondrial matrix ([@B97]). Estimated concentrations for yeast ScGrx1 and ScGrx2 range from 3.4 n*M* to 6.5 μ*M* ([Table 2](#T2){ref-type="table"}). Second-order rate constants of Grx with glutathionylated substrates, including GSSG, are usually between 10^5^ and 10^6^ *M*^−1^s^−1^ ([@B22], [@B96], [@B300]), whereas common thiols have *k*~2~ values that are 10^3^- to 10^8^-times smaller ([Table 3](#T3){ref-type="table"}) ([@B198], [@B266]). A kinetic competition between a protein thiol and Grx for GSSG or GSSR is only possible if the concentrations of Grx and the protein thiol differ by the same order of magnitude. Such a scenario is unlikely for cytosolic proteins. Thus, peak concentrations of cytosolic GSSG rather yield Grx(SSG) than protein(SSG) as an intermediate product. A subsequent enzymatic transfer of the glutathione moiety from Grx(SSG) to a protein cysteine residue is, in principle, possible. However, such a reaction has to compete with millimolar GSH and rate constants between 6 × 10^3^ and 5 × 10^5^ *M*^−1^s^−1^ ([Table 3](#T3){ref-type="table"}). Protein glutathionylation therefore requires a high protein concentration, an unusual rate constant, or kinetic uncoupling of Grx catalysis from GSH because of an altered reductive half-reaction ([Fig. 7](#f7){ref-type="fig"}). Enzymatically inactive Grx isoforms are uncoupled, provide the properties to sense GSSG ([@B60], [@B73]) and might transfer the glutathionylation signal to specific transducer proteins in accordance with the concept on redox signaling from Ref. ([@B34]).

The competition between protein thiols and Grx also brings us back to the four possible mechanisms for the rapid recovery of intracellular E′~GSH~ values after oxidative challenge ([Glutathione concentrations](#s012){ref-type="sec"} section). Peak concentrations of GSSG are very temporary, and the number of cytosolic GSSG molecules under steady-state conditions is probably small. As I just outlined, a Grx-independent buffering of cytosolic GSSG as protein(SSG) does not make sense. Whether there is a transient Grx-catalyzed glutathionylation of proteins depends on the competition between Grx and the GR- or transporter-catalyzed removal of GSSG. GR from rat has a *k*~cat~^app^/*K*~m~^app^ value for GSSG of 4.9 × 10^6^ *M*^−1^s^−1^ ([@B37]), which is roughly 10 times faster than the *k*~2~ value of Grx ([Table 3](#T3){ref-type="table"}). Thus, efficient Grx-catalyzed protein glutathionylation (*e.g*., for redox signaling) should only occur if the GR concentration is lower than the Grx concentration. Further quantitative data on GR, Grx, and GSSG transporters are necessary to decipher the exact fate of GSSG on oxidative challenge.

It is interesting to note that a hypothetical temporary depletion of NADPH on oxidative challenge will have a direct effect on the activity of GR, whereas the activity of Grx is not affected. When the GSSG concentration rises and GR stays inactive, Grx could glutathionylate a number of proteins. Such a metabolic flux should occur in GR-deficient cells, which are presumably viable because (selected) glutathionylated proteins are also substrates of the Trx/TrxR system as demonstrated *in vitro* ([@B79], [@B139]). A similar situation might occur in the secretory pathway of yeast, which lacks GR but harbors ScGrx6 and ScGrx7 ([@B132], [@B184]). Whether these enzymes catalyze glutathionylations or deglutathionylations should depend on the ratio between GSSG and GSH ([Fig. 2](#f2){ref-type="fig"}). Whether specific PDI isoforms exert similar glutathione-dependent functions on oxidative protein folding in mammals and other eukaryotes requires more quantitative and qualitative data *in vivo* (Modified Cysteine Residues section) ([@B8], [@B170], [@B209], [@B272]).

In summary, a general accumulation of glutathionylated proteins during oxidative challenge is unlikely to occur *in vivo* and would necessitate a permanent depletion of NADPH. Nonenzymatic GSSG-dependent glutathionylations are outcompeted by enzymatic glutathionylations when Grx are present. Enzymatically active Grx prevent or immediately reverse glutathionylations at millimolar GSH concentrations. GSSG-dependent protein glutathionylations require special conditions such as (i) high local GSSG concentrations (*e.g*., when GR or GSSG transporters are absent or inactive) or (ii) kinetic uncoupling mechanisms (*e.g*., to transfer the glutathione moiety from an inactive Grx isoform to a specific transducer).

Kinetic competitions for radicals {#s037}
---------------------------------

The substrate O~2~^•−^ of superoxide dismutase is one of the most important radicals in biology. Is a nonenzymatic reaction between O~2~^•−^ and GSH of any physiological relevance? The reaction rate of superoxide dismutase ranges from 5 × 10^−8^ to 6 × 10^−6^ *M*/s at a hypothetical O~2~^•−^ concentration of 0.1 n*M* (using the calculated concentration for cytosolic superoxide dismutase between 0.23 and 31 μ*M* from [Table 2](#T2){ref-type="table"} and the rate constant from [Table 3](#T3){ref-type="table"}). At a GSH concentration of 13 m*M* ([@B212]), the enzymatic reaction of superoxide dismutase is four to six orders of magnitude faster than the nonenzymatic reaction with GSH. Thus, there is no way that GSH has any relevance for O~2~^•−^ removal in the cytosol. Such a reaction might only play a role in a compartment that is (i) devoid of superoxide dismutase, (ii) contains only low concentrations of competing flavo-, heme-, or iron--sulfur cluster proteins, and (iii) has a pH value above 6 (otherwise the spontaneous disproportionation of O~2~^•−^ is faster).

However, GSH might play a role in scavenging other radicals that react with any available electron donor in a diffusion-controlled manner. The rate constants of radical reactions and the high GSH concentration obviously increase the likelihood for the formation of the thiyl radical GS^•^. From there on one can go through many potential reactions on paper. Whether this "paper chemistry" is really relevant *in vivo*, or whether GS^•^ is just another link in a detrimental chain reaction, might depend on the presence and concentration of other compounds such as NO^•^, ascorbate, and maybe Grx ([@B38], [@B95], [@B97], [@B147]). For example, GSNO is sometimes suggested to be formed by GS^•^ and NO^•^. However, even at a high NO^•^ concentration, the GS^•^-dependent formation of GSNO is questionable because of a competition with the O~2~^•---^dependent formation of peroxynitrite (Reactive Oxygen and Nitrogen Species section). The rate constant for the reaction of NO^•^ with GS^•^ is about one order of magnitude smaller than for the reaction with O~2~^•−^ ([@B38]). Whether the metabolic flux is now directed toward the formation of peroxynitrite or GSNO highly depends on the steady-state concentrations of GS^•^ and O~2~^•−^. Although there appear to be no quantitative data on the steady-state concentration of GS^•^, I would be surprised if it is 10 times higher than the concentration of O~2~^•−^. The detection of GS^•^ by sensitive spin traps required, for example, the continuous treatment of neuroblastoma cells with ∼0.3 m*M* H~2~O~2~, whereas no GS^•^ was trapped in unstressed controls ([@B155]).

In summary, a GSH-dependent detoxification of radicals and the NO^•^-dependent formation of GSNO are presumably of little physiological relevance and would require highly specialized reaction conditions because of unfavorable kinetic competitions. However, when iron ions are liberated from damaged iron--sulfur clusters during oxidative challenge (Modified Cysteine Residues section), GSH could contribute electrons to detrimental Fenton reactions ([@B197]). This might lead to local glutathionylations and the formation of O~2~^•−^, H~2~O~2~, and ^•^OH. In such a scenario, nonenzymatic single-electron exchanges with GSH would rather enhance the formation of harmful radicals instead of scavenging them as an "antioxidant".

Mother Nature Invented Glutathione: But Why So Much? {#s038}
====================================================

Hypothesis I: high GSH concentrations are crucial for redox homeostasis {#s039}
-----------------------------------------------------------------------

This imprecise hypothesis subsumes numerous parameters, including enzymatic and nonenzymatic reactions between multiple partners. As outlined in the previous sections, nonenzymatic reactions of GSH with O~2~^•−^, H~2~O~2~, and disulfides are too slow and cannot compete with enzymes even at millimolar GSH concentrations. Enzymatic reactions with O~2~^•−^ and H~2~O~2~ also occur without a glutathione system, and glutathione-dependent hydroperoxidases are rather the exception than the rule. Furthermore, such enzymes work with ping-pong mechanisms and their catalytic efficiency is constant and does not depend on high GSH concentrations. One might argue that apparent substrate saturations play a role. However, nanomolar hydroperoxide concentrations and the established rate constants do not necessitate millimolar GSH concentrations to maintain the hydroperoxidases in a reduced state. This should also be the case for nanomolar GSSG concentrations and the Grx-catalyzed reduction of disulfides, even though these reactions are reversible. A common argument is that high GSH concentrations are necessary to fully reduce redox proteins such as Grx at equilibrium, because---in contrast to dithiol reductants such as dihydrolipoate or Trx---the half-cell reduction potential *E*′~GSH~ not only depends on the standard *E^o^*′~GSH~ value (−0.24 V at pH 7.0 and 25°C) and the \[GSH\]/\[GSSG\] ratio but also on the total concentration of glutathione ([@B10], [@B101]). However, metabolism is not at equilibrium and the reversibility of the reduction of disulfide substrates (*e.g*., of ribonucleotide reductase) should remain unproblematic even at lower glutathione concentrations as long as the (GSH)^2^/GSSG ratio is maintained and the metabolic flux is sufficiently high. Both aspects are ensured by the rapid GR-dependent removal of GSSG and the high, substrate concentration-independent catalytic efficiency of Grx. The same principle should apply to the GSH/GSNO couple as long as there is an efficient GSNOR-dependent removal of GSNO.

The only situation that appears to necessitate a higher GSH concentration for redox homeostasis is the extreme oxidative challenge. The more GSH available, the more oxidants can be immediately buffered resulting in a temporary increase of GSSG. The question is whether such challenges are of general relevance and really reflect a basic principle in biology. For example, deletion of GR in yeast and harsh treatment with 1 m*M* H~2~O~2~ resulted in a temporary increase of cytosolic GSSG with a peak concentration of 140 μ*M*. The same treatment resulted in wild-type cells in a minuscule temporary change of the (GSH)^2^/GSSG ratio ([@B192]). Thus, even under extreme conditions, the buffer capacity of the GSH pool was hardly ever utilized. One might argue that the situation is different in other organisms or subcellular compartments (*e.g*., in human cells or in the secretory pathway) and that different enzyme repertoires and transport processes will affect the glutathione fluxes. This is certainly true for other organisms. For example, exogenous H~2~O~2~ concentrations between 10 and 100 μ*M* yielded minor and major temporary changes of the (GSH)^2^/GSSG ratio in HeLa cells ([@B112]), indicating that not only the Trx/TrxR system but also the glutathione system responded to the challenge in contrast to yeast. However, it is unlikely that requirements in the secretory pathway or other subcellular compartments dictate the high cytosolic GSH concentration in eukaryotes, in particular, taking into account that millimolar glutathione concentrations are also found in bacteria.

In summary, the presence of alternative hydroperoxidases and electron donor systems, as well as the kinetic patterns and activities of Prx, GPx, Grx, and GR, raises the question whether millimolar GSH concentrations are really necessary for redox homeostasis. Even under physiological oxidative challenge, the buffer capacity of the GSH system might be hardly ever used depending on the organism and genetic background.

Hypothesis II: high GSH concentrations are crucial for detoxifications {#s040}
----------------------------------------------------------------------

This hypothesis subsumes the removal of heavy metals, xenobiotics, and endogenous harmful metabolites such as 2-oxoaldehydes, formaldehyde, or 4-hydroxy-2-nonenal ([Fig. 1](#f1){ref-type="fig"}). Depending on the toxin, a few molecules might be sufficient to alter the genome or to poison the organism. Furthermore, a high GSH concentration might be completely irrelevant for most of the life span (or under axenic laboratory conditions) but becomes immediately essential once the organism is exposed. This selection pressure might have favored permanent millimolar glutathione concentrations at an early time point in the course of evolution, in particular, if we consider that the corresponding enzymes often have sequential kinetic patterns so that the catalytic efficiencies increase with higher GSH concentrations. Please note that *K*~m~^app^ values of GST isoforms usually reflect a real substrate affinity. Thus, high GSH concentrations also help to scavenge the toxin by lowering the *K*~m~^app^ value.

Among the candidate detoxification systems and substrates that could necessitate high glutathione concentrations, glyoxalases deal with a very basic chemical challenge: the removal of glycolysis-derived methylglyoxal. However, we can exclude these enzymes and 2-oxoaldehydes from the list because (i) glyoxalases are often nonessential, (ii) high GSH concentrations inhibit Glo2, and (iii) some organisms have methylglyoxal reductase or other GSH-independent enzymes that can also do the job ([@B60], [@B61], [@B129], [@B256]). We can also exclude the activities of GSNOR and GSH-dependent formaldehyde dehydrogenases because these enzymes are often missing in glutathione-utilizing pro- and eukaryotes. The best candidates are indeed the numerous GST isoforms. They are the most widespread and diverse glutathione-dependent enzymes and they are able to remove potentially deadly mutagens and poisons ([@B6], [@B30], [@B60], [@B117]). Among the numerous GST and MAPEG members, we can exclude the specialized isoforms that contribute to amino acid catabolism or to steroid and eicosanoid biosynthesis ([Fig. 1](#f1){ref-type="fig"}) ([@B60], [@B117], [@B135], [@B176]). For the remaining vast majority of isoforms, we encounter the dilemma of how to quantitatively address the relevance of millimolar GSH concentrations for detoxification processes without knowing the identity and compartment-specific concentrations of the relevant enzyme--substrate couples in real ecosystems.

Hypothesis III: high GSH concentrations are crucial for iron metabolism {#s041}
-----------------------------------------------------------------------

The hypothesis is counterintuitive because nonenzymatic reactions between GSH and free iron ions could promote harmful Fenton reactions. However, biochemical systems are adopted to limit free iron ions. Furthermore, genetic studies in yeast support hypothesis III ([@B153], [@B194], [@B214], [@B241]). Best candidates for an important link between iron and glutathione metabolism are evolutionarily conserved Grx isoforms that are able to bind iron--sulfur clusters (Orphan Proteins and Unknown Metabolites and Substrates section). The stability of these clusters was shown to not only depend on the presence ([@B17], [@B161], [@B164], [@B228], [@B302]) but also on the concentration of reduced GSH *in vitro* ([@B183]). However, nothing is known about the steady-state concentrations of Grx-bound \[Fe~2~S~2~(GS)~2~\] clusters and many rate constants are missing to support the hypothesis. We only know that the cluster transfer from Grx has an intermediate rate constant, as has been reported for poplar chloroplast monothiol GrxS14 and ferredoxin ([Table 3](#T3){ref-type="table"}) ([@B17]). On the one hand, the Grx-bound cluster has to be accessible and should not be bound too tightly to facilitate the critical transfer between proteins. On the other hand, the cluster should be shielded from O~2~^•−^ and H~2~O~2~. This presumably reflects a dual function of glutathione, which might be easily stripped off during the cluster transfer and also shields the iron ions. Both parameters should depend on the Grx isoform and function. Thus, a quantitative analysis of the relevance of glutathione for iron--sulfur cluster metabolism boils down to potential kinetic competitions between GS^−^, O~2~^•−^, H~2~O~2~ and donor and acceptor proteins regarding their cluster interactions. Almost all relevant rate constants of these processes seem to be unknown. For example, whether millimolar GSH concentrations are necessary to shift the equilibrium from the unprotected to the protected cluster species depends on the rate constants for GS^−^ binding and dissociation. In summary, many more rate constants and concentrations are necessary to quantitatively address the relevance of millimolar GSH concentrations for iron metabolism.

Concluding Remarks {#s042}
==================

Recent discoveries have challenged the traditional view of glutathione metabolism that was predominantly based on concepts of redox homeostasis and oxidative stress. The focus has clearly shifted from antioxidant defense to the compartmentalization of glutathione-dependent pathways, redox regulation, and the relevance of glutathione for iron metabolism. So far, there appears to be no unambiguous explanation for the millimolar concentration of GSH, and the glutathione puzzle remains incomplete. It still comprises numerous missing pieces, including compartment-specific transporters, substrates, and enzymes as well as crucial quantitative data regarding concentrations, rate constants, and enzyme kinetic patterns. I tried to emphasize the importance of each of these parameters and provided examples how to use them to compare the rates of potentially competing reactions with hydroperoxides, disulfides, or radicals. Such a quantitative approach could be also helpful to unravel the relevance of the other functions of glutathione, which can differ significantly among organisms, cell types, and subcellular compartments. The presented model on uncoupling mechanisms might be useful to address fundamental aspects of iron--sulfur cluster biogenesis, redox sensing, and oxidative protein folding. Future qualitative and, in particular, quantitative analyses will certainly reveal novel unexpected insights on glutathione metabolism and tell us whether we were on the right way or just guessing at numbers and figures.
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